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CHAPTER Ι 
GENERAL INTRODUCTION 
Chapter I. GENERAL INTRODUCTION 
Multiple sclerosis (MS), a neurological disease expressing variable function 
losses, is accompanied by prominent demyelInation and gliosis in the central 
nervous system (CNS). Active demye1 i nat i on generally occurs in the presence of 
infiltrations, consisting of mononuclear leucocytes (macrophages and 
lymphocytes) of vascular origin. The underlying cause for the occurence of 
these processes is unknown, although epidemiological studies revealed a 
possible role for environmental factors during early childhood, as well as for 
genetic factors (Schelnberg and Raine 1984). 
Experimental autoimmune encephalomyelitis (EAE). which is induced through the 
immunization of animals with myelin or certain myelin components, resemoies MS 
both clinically and histologically, in particular the chronic or 
relapsing-remlttlng form of EAE. Furthermore, the existence of resistant 
animal strains as well as the influence of the animals' age at the time of 
Immunization further strengthen the homology with MS (Alvord et al. 1984). 
However, the versatility of EAE as a model for MS has been limited by the 
equivocal Involvement of the major encephalitogenlc component of CNS myelin, 
myelin basic protein (MBP) In MS. Furthermore, immunization of animals with 
purified MBP generally induces an acute disease with an early onset and only 
minimal demyelination. much unlike MS (Raine et al. 1981a). 
It has been known for some time, that proteolipid protein (PLP. occasionally 
referred to as lipophllin). which forms the major protein component of CNS 
myelin, also induces EAE upon immunization of several animal species (Camoi et 
al. 1983. Madrid et al. 1982). Clinically and histologically the disease 
differs from MBP-Induced EAE by a delayed onset and a chronic disease course, 
as well as widespread demyelination, thus offering a potentially better model 
for MS than MBP-Induced EAE. 
The present review will address several mechanisms of demyelination and related 
processes, focussing on recent developments, since review articles covering 
earlier work have been published recently (Raine 1984, Yonezawa 1983). For 
additional references the reader Is referred to the chapters pertaining to the 
specific topics. 
Before addressing the issue of autoimmune demyelInation Itself, an important 
preceding process will be discussed first, namely the mechanism by which 
myelln-speclfic Τ cells, the sine-qua-non of EAE, Infiltrate the CNS and 
recognize their antigen. This section will include the characterization of the 
T-cell subsets Involved In the process of CNS infiltration. 
A) CELLULAR INFILTRATION OF THE CNS. 
One of the possible mechanisms of infiltration is the breakdown of the 
blood-brain barrier by a T-cell unrelated mechanism, resulting In the passive 
entrance of the CNS by many blood components, including the encephalitogenlc Τ 
cells. A role in this process has been proposed for bacterial adjuvants, like 
Bordetella pertussis (Llnthicum and Frellnger 1982). 
A second and widely studied possibility is the presentation of myelin antigens 
by endothelial cells in brain capillaries, resulting in the activation of 
cuculating myel in-specific Τ cells. Consequently, these activated Τ ceils 
could damage the blood-brain barrier locally and thus enter the CNS. 
The observations leading to this hypothesis focussed on the expression of the 
major histocompatibility complex (MHO class II-related la glycoproteins on 
endothelial cells, coinciding with the CNS infiltration in EAE (Sobel and 
Col vin 19Θ5, McCarron et al. 1985) and in MS (Traugott et al. 1985). Ia 
molecules generally form a necessary component in the presentation of antigen 
to Τ lymphocytes, as discussed later. 
Among the effector mechanisms that are active during the endothelial disruption 
in other inflammatory events, like the Arthus reaction, is the activation of 
complement (Asghar 1984), which could thus be Involved in the infiltration of 
the CNS. (The involvement of complement in other processes related to 
demye1 i nat 1 on will be discussed later.) 
A third and less accepted line of research on the mechanisms of CNS 
infiltration, focusses on the possibility, that activated Τ cells, 
irrespective of their specificity, generally enter the CNS more readily than 
unactivated Τ cells (Wekerle et al. 1986), possibly through the elaboration ot 
endoglycosidase (Cohen 1984). 
After the in vitro activation by concanavalin A (Con A) and the subsequent 
injection into syngeneic animals, Τ cells that express brain-unrelated 
antigenic specificities infiltrate the CNS, but disappear shortly after, 
while the Τ cells with antigenic specificities towards myelin remain in tne 
CNS and somehow set the stage for encephalomyelitis (W.F. Ніскеу, unpublished 
observations, 1987). 
This view is opposed by the classical dogma of the CNS as an immunologically 
privileged site, mainly pertaining to the unique absence of a lympnatic 
draining system In this organ (Wikstrand and Bigner 1980). However, careful 1 
analysis revealed the presence of low but consistent levels of Τ cells in 
normal CNS (Booss et al. 1983). 
В) DISTRIBUTION OF T-CELL SUBSETS INSIDE THE CNS. 
The relative distribution of T-cell subsets in the process of CNS infiltration 
has been studied extensively in MS. 
The reported accumulation of CD8+ (suppressor-cytotoxlc) cells over CD4+ or 
hel per/inducer cells (Woodroofe et al. 1986, Hauser et al. 1986) contrasts 
with reports on the uniformity in the T-cell distributions between the CNS and 
the peripheral circulation (Brinkman et al. 1982, Nyland et al. 1982). 
Agreement however exists on the relative decrease in the number of CD8+ cells 
in peripheral blood during or preceding disease activity (Hauser et al. 1983. 
Oger et al. 1986, Mickey et al. 1987). 
Using the EAE model, studies on some possible explanations for the 
discrepancies in the observed T-cell distribution inside the CNS will be 
reported in this thesis. The Identity of the infiltrating cells is an 
important issue, since it might contribute to the identification of the cells 
that regulate demye1 i nat ion. 
С) SPECIFIC CELL-MEDIATED MECHANISMS INDUCING DEMYELINATION. 
The cells that are essential in the adoptive transfer of EAE have been 
characterized as CD4+, helper Τ lymphocytes (Swanborg 1983, Brostoff and Mason 
1986). 
The mechanism by which these helper Τ cells effectuate myelin disruption is 
still unclear. Several possibilities exist, for Instance the peripheral 
stimulation of effector systems, like cytotoxic or otherwise effective Τ 
cells. В cells or their products, which subsequently penetrate the blood-brain 
barrier and cause demyeii nat i on, although little evidence exists to support 
this mechanism. 
Alternatively, the activated helper Τ cells themselves enter the CNS, as has 
been documented (Naparstek et al. 1983), and could stimulate effector systems 
locally, after recognition of their antigen. 
The exact identity of the dominant effector mechanisms is still unclear. 
Evidence for the involvement of CD8+ cytotoxic Τ cells during demyeiination is 
sparse, although suggestions have been made for some role in MS (Merrill et 
al, 1984, Weber et al. 1987). 
On the other hand, Tabira and Sakal (1987) reported that transferred 
encephalitogenic T-cell clones Induce demyeiination without the involvement of 
recipient-derived Τ cells, thus arguing against a role for any non-helper Τ 
cell, like cytotoxic Τ cells. In addition, encephalitogenic helper T-cell 
lines Induce demyeiination in organotypic CNS cultures (Lyman et al. 1986), 
Indicating that no other peripheral immune cells are required to start the 
demyeiination. 
Although a few reports suggested the existence of direct effects of 
encephalitogenic Τ cells, namely the inhibition of myelinated axon activity 
(Yarom et al. 1983) or cytotoxicity towards antigen-presenting astroglia (Sun 
and Weker le 1986), the mechanism in helper Τ cel 1-mediated demyeiInation is 
more likely to be indirect, namely through the induction of a DTH response 
following recognition of myelin antigens by the encephalItogenic Τ ceils. This 
mechanism has been suggested to occur In MS as well (Traugott et al. 1983). 
This brings up the issue of antigen presentation In the CNS, which will be 
addressed here briefly, before discussing the effector mechanisms of 
demyeiination. 
In general, Τ cel 1-dependent immune responses require the initial antigen 
presentation to the specific helper Τ cells by an antigen-presenting cell in 
the context of la molecules, that bind antigenic peptides after intracellular 
antigen processing. The la-antigen complexes are subsequently exposed on the 
surface of the antigen-presenting cell (Unanue and Allen 1987). In the CNS, 
the function of the antigen-presenting cell could be performed by either 
endothelial cells (McCarron et al. 1985), infiItrating monocytes or local 
glial cells, namely astroglia (Fontana et al. 1984, Traugott et al. 1985) or 
microglia. Notably the role of microglia has recently been stressed frequently 
(Woodroofe et al. 1986, Suzumura et al. 1987, Hayes et al. 1987, Matsumoto et 
al. 1986). 
An important issue in neuroimmunology is the cause of the Initial processing 
and presentation of myelin antigens. One possibility is a preceding CNS 
inflammation caused by an infectious agent, like a virus, which would damage 
the myelin (possibly through bystander demye1 i nat i on, as discussed later) ana 
result in the phagocytosis of myelin and the presentation of myelin antigens 
by macrophages, that were activated earlier as a result of the virali y induced 
inflammation. The existence of potentially autoimmune Τ cells, capaole of 
recognizing the presented myelin antigens in normal animals, has been reportea 
(Schluesener and Wekerle 1985). Fran here on, an autoimmune response could 
take over, as suggested by the results of Watanabe et al. (1983), who were 
able to transfer EAE with lymphocytes from virally infected animals (without 
concomitantly transferring the virus). In addition, infection with semliki 
forest virus, a CNS-infecting virus, renders otherwise resistant animals 
susceptible to EAE induction (Mokhtarian and Swovelana І987). 
A plausible alternative mechanism leading to secondary autoimmunity as a result 
of CNS infections, is the immunological cross-reactivity between the infecting 
agent and myelin components (Fujinami and Oldstone 1985, Shaw et al. 1986). 
Other noninfectious events that are capable of initiating myelin disruption and 
thus possibly Induce secondary autoimmunity, include traumas (Poser 1987). 
However, none of the initiating events discussed above seem to apply to the 
process of antigen presentation to activated encephalitogenic Τ cells after 
their transfer into naive animals. Possibly, the in vitro-activated Τ cells 
infiltrate the CNS of the recipients, where they secrete activation products 
for resident microglia, which in turn produce myelin-disrupting substances, 
and, after phagocytosing and processing the myelin, present myelin antigens, 
thus restimulat ing the encephalItogenic Τ cells. Alternatively, some degree of 
myelin processing and presentation may occur normally, resulting in the direct 
stimulation of infiltrating Τ cells. These possibilities however are 
speculative and lack experimental support. 
In general, the local restimulation of antigen-specific Τ cells results in a 
DTH-type response, including the infiltration of non-specific mononuclear 
cells like macrophages and the subsequent tissue breakdown (Bretscher 1986). 
D) EFFECTOR MECHANISMS OF DEMYELINATION. 
The involvement of macrophages in the breakdown of myelin has obtainea ample 
documentation. The actual stripping of myelin has been shown to occur (Brosnan 
et al. 1977), and seems to be related to coated pits connecting the 
macrophages to their target in both EAE (Epstein et al. 1983) and MS, where 
IgG has been identified as a component of these coated pits, suggesting the 
occurence of antibody-mediated phagocytosis (Prineas and Graham 1981). 
Besides Infiltrating macrophages, resident microglia have also been implicated 
in the phagocytosis of myelin (Liu and Shen 1985). 
In addition, the in vitro antibody-mediated phagocytosis of myelin has been 
reported (Smith and deJong 1987, Trotter et al. 1986). 
This introduces the issue of ant ibody-induced demye1 i nat i on. Antibodies to the 
thusfar major encephalitogenic myelin component MBP have been known for some 
time not to cause demyelination (Seil et al. 1968, DriscoU et al. 1986). and 
their role, if any, remains unknown. 
Antibodies to other myelin components however, mainly galactocerebroside (GO, 
show demyelinative capacity both in vitro (Raine et al. 1981b) and in vivo 
(Sergott et al. 1984, Hughes et al. 1985). In addition, the titer of GC 
antibodies is elevated in the CSF of MS patients (Kasai et al. 1986). 
Although the Immunization with GC alone does not cause CNS inflammation and 
demyel1 nat i on, a superimposed inflammatory reaction results in 
anti-GC-mediated demyelinat ion. The aforementioned inflammatory reaction can 
be induced by the intracerebral introduction of PPD, the purified protein 
derivative of Mycobacterium tuberculosis, following immunization with GC in 
the presence of M. tuberculosis (Brosnan et al. 1983). 
The difference in the demyelInating activity between antibodies to MBP and GC 
can be explained by the presumptive intracellular localization of MBP 
(Dickinson et al. 1970), which is thus normally concealed from humoral immune 
surveillance. GC on the other hand is expressed on the extracellular surface 
of myelin lamellae (the intraperiod lines of myelin), which possibly explains 
the demyelinating capacity of its antibodies. 
PLP, in contrast to MBP and GC, expresses both encephalitogenic and 
demyelinating capacities upon Immunization (Cambi et al. 1983), and is in part 
localized extracel lularly (Lees et al. 1984, Stoffel et al. 1984). The 
elucidation of a role for PLP antibodies in EAE is therefore potentially 
important. In addition, the lack of evidence for specific MBP immunity in MS 
increases the interest in other potential MS-related antigens besioes MBP. 
Although subsequent activation of complement is necessary for the effectuation 
of humoral antibody-mediated myelin breakdown (see below), in the absence of 
complement the myelin antibodies cause a reversible increase in the myelin 
periodicity ("swelling" of myelin) (Bornsteln and Raine 1976), ana might thus 
set the stage for the subsequent breakdown by complement and macrophages. 
The role of activated complement as the effector mechanism In 
antibody-mediated, non-phagocytic demyelination has been clearly established. 
mainly using organotypic cultures (Liu et al. 1983, Roth et al. 1983). 
E) ANTIGEN NON-SPECIFIC DEMYELINATΙΟΝ. 
1) Cellular mechanisms. 
The processes described thusfar are directly related to the immune-specific 
recognition (either cellular or humoral) of myelin antigens. In this 
paragraph, potential myelin-disrupting processes will be discussed, that are 
not directly related to myelIn-specific immune recognition. 
It has been known for some time that activated Τ cells, specific for 
brain-unrelated antigens, are capable of causing CNS inflammation and 
demyelination, following the introduction of antigen into the CNS, as 
described before. Thus, the simultaneous peripheral Immunization and 
intracerebral injection of the same antigen result in CNS inflammation and 
so-called bystander demyelination (Wisniewski and Bloom 1975, Holoshitz et al. 
1984). 
Apparently, myelin is susceptible to degradation when an Inflammatory, DTH-type 
reaction against non-myelin antigens occurs in its vicinity, indicating that 
activated Τ cells induce antigen-nonspecific processes to cause demyelination. 
However, some disagreement exists on this matter (Goban et al. 1986). 
More recently, an example of bystander demyelination was provided by Lyman et 
al. (1986), who showed that all T-cell lines, that were tested in organotypic 
CNS cultures, caused myelin damage. Irrespective of their antigenic 
specificity, although the CNS-specific Τ cells induced the strongest 
breakdown. 
Similar results have been reported using the supernatants from nonspecifleally 
stimulated lymphocytes from healthy individuals, although stronger effects 
were obtained with MS patients' lymphocytes (Selmaj et al. 1986). These 
studies on organotypic CNS cultures do not clarify whether the 
myelin-disrupting effect of lymphocytes or their secretory products is direct 
or through the activation of resident immunoreactive cells in the CNS, like 
mlcroglia. 
It should be stressed at this point, that bystander demyelination differs 
immunologically from the earlier described secondary autoimmunity, in that the 
former is totally myelin-nonspecific, while in the latter the second stage is 
myelin-specific. On the other hand, these two separate processes are not 
necessarily incompatible, since under some circumstances bystander 
demyelination can be expected to result in autoimmunity towards myelin. 
The human equivalent of these two processes is probably a viral CNS infection, 
as shown by the occurence of encephalomyelitis following measles infection 
(Johnson et al. 1984). A similar mechanian could also occur in MS, where a 
viral infection during childhood has been suggested. Furthermore, the 
demyelinating reaction in MS could be totally or for a major part 
antigen-nonspecific, as suggested by the apparent absence of specificity in 
both the antibody level (Lisak 1980) and the T-cell content In CSF, the latter 
showing a wide range of unidentical gene rearrangements (Rotteveel et al. 
1987). In addition, a decreased ability to control the nonspecific lymphocyte 
proliferation in MS has been suggested (Starosta and Birnbaum 1987). 
Macrophages, besides their antibody-mediated phagocytic activity, are 
considered to be involved in nonspecific myelin disruption as well, mainly 
through secretory products, which include proteases and protease activators 
(Cammer et al. 1978, Onìshi 1984), lactic acid (Young and Zygas 1986). 
phosphol1pases (Trotter and Smith 1982) and other inflammatory mediators, like 
complement components (Allison 1978). In addition, microglia are likewise 
involved in dysmyelinating disorders (Matthieu and 0ml in 1984). 
Consequently, macrophages are strong candidates for the role of effector cells 
in both the specific and nonspecific or bystander demye1 i nat i on, serving as an 
alternative mechanism for any directly disrupting effect of the 
encephalitogenic lymphocytes. 
2) Humoral mechanisms. 
Although the distinction between humoral and cellular Immune processes Is 
fading, since ever more cellular processes are shown to be mediated through 
secretory products, the mechanisms described below are generally considered to 
be humoral. The potential importance of humoral processes during demyelination 
is stressed by the occurence of myelin disruption in the absence of cellular 
infiltrations in certain forms of EAE (Vandenbark et al. 1986, Alvord et al. 
1985), as well as in Wallerian degeneration (Reigner et al. 1981). 
Furthermore, the digestion of MBP outside plaque areas has been reported to 
occur in MS (Adams et al. 1971). In addition, MS sera have been known for some 
time to posses increased demyelinating capacity, which in contrast to EAE. has 
been reported to be mainly unrelated to antibodies (Johnson and Bornstein 
1978, Grundke-Iqbal and Bornstein 1980, Bradbury et al. 1984). 
In addition to its role in specific antibody-mediated demyelination (vide 
supra), complement activation by myelin also occurs in the absence of 
myelin-specific antibodies (Ghandi et al. 1985). The identity of the myelin 
component responsible for this process is unclear, since either MBP (Cyong et 
al. 1982), or a different high molecular-weight protein with unknown identity 
(Vanguri and Shin 1986) have been proposed. Furthermore, normal serum also 
shows complement-dependent demyeli nat ing activity (Silberberg et al. 1984). 
Considering the reports on changes in the complement profile during EAE 
(Morariu and Dalmasso 1978) as well as In MS (Compston et al. 1986), the 
results described thusfar render complement a plausible target for 
disease-suppression experiments. 
Proteases such as plasmin activate complement directly (Brown 1975) and could 
thus be involved in, or add to the nonspecific complement activation by 
myelin. 
In addition, proteolytic activity towards myelin has been demonstrated in 
normal serum (Appel and Bornstein 1964, Konat and Offner 1982) and CSF 
(Inuzuka et al. 1986). Likewise, endogenous proteases, that are present in 
myelin could be involved in myelin breakdown and have been reported to snow 
elevated levels in myelin from MS patients (Sato et al. 1984). 
In general, proteases form an important component in the effector stages of 
Inflammation (Bever and Whitaker 1985), as well as in other immune processes 
(Takayama et al. 1987). Their activity is restricted by protease inhibitors, 
which thus act as Immune suppressors (James 1980, Hubbard et al. 1981, 
Revillard et al. 1984, Hart 1986). The inactivation of protease inhibitors 
could therefore be involved in the continuation of inflammatory aemyelination 
(Breit et al. 1985). 
Interestingly, protease inhibitors in serum have been linked to MS in several 
ways (Koetsier et al. 1981, McCombe et al. 1985, Rastogi and Clausen 1985). 
Although a direct role for proteolytic activity in the disruption of fresh, 
unfrozen myelin has been shown to occur (Inuzuka et al. 1984, Wood et al. 
1974), proteolytic breakdown is enhanced by prior disruption of the myelin 
through freezing (Marks et al. 1976) or complement activity (Cammer et al. 
1986), due to the relative Inaccessibility of myelin proteins in intact, fresh 
myelin. 
The proteolytic breakdown of myelin could therefore be preceded by separate 
initiating events, that disrupt the compact structure of myelin. These events 
probably Involve lipid changes or the widening of myelin lamellae by salts or 
low pH. Lipid changes in myelin are induced by complement (Roth et al. 1983), 
or by lipases and lysolecithln. The effect of lipases on the myelin stability 
has not been studied extensively. Phospholipases (A2) Induce the formation of 
lysolecithin, which in turn dissolves myelin (Hall 1972). Phospholipases show 
increased levels in EAE and play a role during in vitro demyelination (Trotter 
and Smith 1986). 
Simple ionic factors like salts (Glynn et al. 1987), calcium (Smith et al. 
1985, Blaurock and Yale 1987) and low pH (Young and Zygas 1986) have been 
shown to destabilize myelin, and possibly contribute to the inflammatory 
myelin disruption as well. 
A frequent problem in demyelinatlon research is the absence of methods to 
monitor the early and probably subtle changes during myelin disruption, with a 
possible exception for the X-ray diffraction studies, showing promising 
results in the study of myelin periodicity (Kirschner et al. 1984, Karthigasan 
and Kirschner 1987). 
In collaboration with Dr. F. Jolesz in Boston we have attempted to use nuclear 
magnetic resonance to detect early changes in isolated myelin, but thusfar 
with little succes (unpublished observations). 
One of the characteristics of myelin, that possibly changes during disruption, 
is its bouyant density. Compared to other membrane systems, myelin has a low 
density, resulting from the high 1ipid-to-protein ratio and the low water 
content (Norton and Cammer 1984). This feature, generally used in the 
purification of myelin, potentially offers a parameter for the early 
alterations in myelin, which result in the disruption. 
In conclusion, this review emphasizes the importance of humoral processes 
during demyelinatlon, including the early, non-specific mechanisms, however 
without reducing the impact of immunologically specific processes. In fact. 
many of the presumed effector mechanians, that are induced by antigen-specific 
Τ cells, such as proteolysis, complement activation and phagocytosis, are 
probably also inducable through Immunologically nonspecific mechanisms. 
F) CONCLUSIONS AND SPECIFIC AIMS. 
The last paragraph of the general introduction comprises several of the 
unresolved issues regarding demyellnat i on, which were discussed in the 
preceding review and addressed in the present thesis. 
The differential Infiltration of T-cell subsets Into the CNS remains a 
controversial, but important issue in MS research. The observation of a 
similar lymphocyte distribution in the infiltrations as in the circulation 
would indicate a rather nonselective entry into the CNS. This finding could 
lead to conclusions, regarding the role of the T-cell subsets in the 
demyelination process, that are different from the situation of a differential 
distribution of the lymphocyte subsets Inside the CNS. In addition, a 
comparison of the infiltration patterns of the subsets among the different CNS 
compartments might indicate specific activities of each subset in relation to 
demyelinatlon, both in time and place. 
The disparity In the results from different Investigators possibly relates 
either to the dynamical expression of membrane markers or alternatively to the 
specific sequestration of the different T-cell subsets among the various CNS 
compartments. 
These issues will be addressed in Chapter II. 
A substantial drawback in the use of EAE as a valid model for MS is the 
uncertainty over the role for MBP in the latter, as well as the absence of 
widespread demyelination in EAE. following immunization with MBP. An important 
question therefore is whether immunization with different myelin antigens can 
give rise to similar CNS-inflltration patterns as with MBP, and yet offer a 
better clinical and histological model for MS. This question was addressed by 
studying the immunohistopathology of a similar disease induced with myelin 
PLP, as described in Chapter III. 
Although PLP-induced EAE revealed similarities to the MBP-induced disease 
immunohistologically, differences were also observed, notably a delay in the 
onset of clinical disease as well as more extensive demyelination. In oraer to 
reveal a possible reason for these differences, the humoral immune response in 
PLP-lmmunized animals was studied longitudinally and compared to the clinical 
course, as reported in Chapter IV. 
The role of the humoral factors in EAE has been discussed extensively in the 
introductory review, with an emphasis on the proteolytic activity during the 
effector stages of demyelination. Because protease inhibitors are considerea 
to regulate excessive proteolysis during inflammation in general, their 
inactivation at the site of inflammatory demyelination could result in more 
extensive and prolonged myelin disruption. In vitro studies on a possible role 
for MBP as an inactivator of protease inhibitors is reported in Chapter V. 
In addition to the direct, but possibly limited proteolysis of myelin, 
proteases could effectuate myelin disruption by directly activating the 
complement system, thus circumventing the requirement for myelin-specific 
antibodies in complement-mediated myelin breakdown. Since complement inauces 
myelin disruption both specifically (through antibodies) and nonspecifically 
(through proteolysis or other unknown process), mechanisms that inhioit the 
complement cascade offer therapeutical potential. These considerations led to 
experiments using the complement inhibitor suramin to study its in vivo effect 
on the course of EAE (Chapter VI). 
Thusfar, in vitro studies on the mechanisms of demyelination have been hampered 
by the absence of a parameter to monitor the early stages of myelin 
disruption, prior to the elimination of large quantities of myelin, which is 
usually measured quantitatively through the loss of myelin proteins. In 
Chapter VII preliminary results are described from efforts to employ changes 
in the bouyant density of myelin as a parameter for the early demyelinating 
processes, using an in vitro myelin-disrupt ion assay. The results have been 
published elsewhere in abstract form (van der Veen 1987). 
Finally, the implications of the results from Chapters II-VII will be discussed 
in Chapter VIII. 
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CHAPTER II 
DISTRIBUTION OF Τ LYMPHOCYTE SUBSET MARKERS DURING SPINAL CORD INFILTRATION 
IN ACUTE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS. 
R.C. van der Veen, H.J. ter Laak and O.R. Honmes. 
(submitted) 
SUMMARY 
To study the differential distribution of Τ lymphocyte subsets 
during acute EAE in Levis rats, circulating leucocytes and serial 
spinal cord sections, sampled at different stages of the disease, were 
stained with monoclonal antibodies against Τ lymphocyte markers. The 
results show that the expression of the marker, labelled by antibody 
V3/13 and present on most circulating Τ cells, decreased after 
infiltration in meninges and continued to decrease in parenchymal 
infiltrations. la expression, labelled by OX-3, increased on 
peripheral mononuclear cells during early EAE development and remained 
at a high level on infiltrated cells. The marker for helper Τ cells, 
recognized by antibody W3/25, showed a fairly constant distribution, 
while suppressor/cytotoxic Τ cells, labelled by OX-8, accumulated in 
the meninges, but not in parenchyma. 
These results show the dynamic nature of lymphocyte surface 
markers, and indicate that Τ cells continue to differentiate inside 
the central nervous system. In addition, suppressor/cytotoxic Τ 
lymphocytes, though accumulated in the meninges, do not seem to play a 
major role in parenchymal infiltrates during the acute EAE course. 
Key Words: Experimental allergic encephalomyelitis (EAE), Lewis rats, 
Τ lymphocyte subsets, Blood, Meninges, Parenchyma 
INTRODUCTION 
During the development of acute experimental allergic 
encephalomyelitis (EAE), an established animal model for multiple 
sclerosis (MS) (Alvord et al., 1984), Τ lymphocytes form a crucial 
component (Ben-Nun and Cohen, 1982) and migrate into the central 
nervous system (CNS) (Lublin et al., 1983). Adoptive transfer 
experiments have shown that transferred effector Τ cells migrate into 
the CNS of the recipient (Naparstek et al., 1982). Furthermore, the 
helper Τ subset forms a key element in the transfer of EAE (Swanborg, 
1983; Brostoff and Mason, 1986). 
During the last decade, the labelling of Τ lymphocyte subsets 
with monoclonal antibodies (MAbs) has found widespread application in 
MS-related research. A major focus of these studies was directed at 
the disease-related increase in the ratio of helper over suppressor-
cytotoxic Τ cells in the circulation in MS (Veiner and Hauser, 1982; 
Huddlestone and Oldstone, 1982; Oger et al., 1986; Mickey et al., 
1987), although in EAE this phenomenon has only been observed in 
monkeys (van Lambalgen and Jonker, 1987), but not in mice (Sriram et 
al., 1982; Hauser et al., 1984) or rats (Fallís et al., 1987). The 
relation between the relative decrease in circulating 
suppressor/cytotoxic Τ cells and disease activity suggested attractive 
explanations for the autoimmune phenomena in MS, depending on the 
proposed fate of these suppressor cells. 
The characterization of infiltrating lymphocytes in the CNS of 
MS patients reportedly presents a similar distribution pattern as 
compared to the circulation (Nyland et al., 1982; Brinkman et al., 
1982). An accumulation of suppressor/cytotoxic Τ cells in the CNS 
however, has also been reported (Hauser et al., 1986; Voodroofe et 
al., 1986). Possible reasons for the lack of uniformity in these 
findings are the dynamics in expression of the markers on the cell 
membrane, or differences in the migration pattern of the Τ cell 
subsets. The purpose of the present study was to address the dynamics 
of Τ cell markers in different CNS compartments and peripheral blood, 
using the acute БАЕ model in Lewis rats. The terms "helper" Τ cells 
(Тд) and "suppressor/cytotoxic" Τ cells (T
s
/C) refer to markers on the 
Τ lymphocyte subsets (CD4 and CD8 respectively), that are primarily 
related to the recognition of different MHC classes during antigen 
binding, but generally express their denoted function (Swain, 1983). 
MATERIALS AND METHODS 
Male Lewis rats, weighing 150-200 grams, were injected 
intradermally with 0.1 ml of an emulsion consisting of guinea pig 
spinal cord homogenate in PBS (200 mg/ml) and an equal volume of 
complete Freund's adjuvant, containing 10 mg/ml Mycobacterium 
tuberculosis (Difco, Detroit). Clinical signs started 9 or 10 days 
after immunization (p.i.) and were maximal after 11 to 14 days p.i., 
followed by recovery. Tissues and blood were sampled either at day 10 
and 11 ("early" EAE) or at day 21, when the animals were essentially 
recovered ("late" EAE). The lumbar part of the spinal cord was 
dissected out immediately and frozen in liquid nitrogen. Longitudinal 
sections (8 urn) were mounted on glass slides. Serial sections were 
stained sequentially with each of four different MAbs and with Sudan 
Black В for myelin. 
The following MAbs were used (Sera lab, England): 0X-3, that 
binds to la on macrophages, В and some Τ lymphocytes (McMaster and 
Williams, 1979); 0X-8, specific for the suppressor/cytotoxic Τ subset; 
V3/25, that binds the helper Τ subset and some macrophages; and 
finally W3/13, that labels both subsets of Τ cells (Williams et al., 
1977, Brideau et al., 1980). The staining procedure was as follows: 
after fixation in acetone (10 min), the sections were incubated with a 
MAb (1:100) for 30 min. After rinsing in PBS, they were incubated 
with peroxidase labelled IgG (rabbit anti-mouse) for 15 min and rinsed 
in PBS. 3-Amino-9-ethyl carbazole (Sigma, St. Louis, M0) was added 
(10 mg in 2.5 ml dimethylformamide and 50 ml 0.1 M acetate buffer, pH 
4.9 and one drop of H202» 30%) for 2.5 min to visualize the location 
of the MAb. Finally, these sections were counterstained with 
haematoxylin Mayer. After counting all the positive and negative 
infiltrating mononuclear cells, the proportions of positive cells in 
the infiltrations of each compartment were averaged. Statistical 
analyses were performed on the tissue data using the Wilcoxon test (a 
» 5%). Heparinized blood from immunized rats was sampled at day 7 and 
11. After lysing the erythrocytes with NH4CI, the remaining 
leucocytes were sedimented in a Burk sedimentation chamber on a glass 
slide, dried and stained as described for the tissue sections. At 
least 100 mononuclear cells were counted and the percentage of 
positively stained cells was determined. 
RESULTS 
Figure 1 shows the results from the characterization of blood 
cells and cellular infiltrations in the spinal cord, using monoclonal 
antibodies against T-lymphocyte markers. Comparison of three 
different body compartments (blood, meninges and parenchyma) reveals 
the folioving distribution patterns of the T-cell markers: The 
proportion of З/13-labelled cells, vhich approached the expected 
value for a total T-cell determinant in blood, shoved a decrease in 
the meninges relative to blood and continued to decline in the 
parenchyma during the course of the disease. The difference between 
meninges and late parenchyma vas statistically significant. W3/25-
labelled cells vere equally abundant in the tissue compartments 
studied, although their number in the tissues vas slightly lower 
compared to blood. The proportion of OX-8-labelled cells was maximal 
in the meninges, where it was significantly larger than in "late" 
parenchymal infiltrations. Both V3/13 and OX-8 numbers in parenchyma 
decreased during the development of EAE, while the OX-3 positivity 
slightly increased, but none of these differences reached statistical 
significance. OX-3 binding in tissue infiltrations and in EAE blood 
was more prominent than in normal blood. This increase in exposure of 
the la antigen on circulating cells was already present 7 days after 
immunization. 
In individual animals the parenchymal infiltrations were 
differentiated into apparently demyelinating and non-demyelinating 
lesions. The demyelinating lesions showed a clear loss of myelin (not 
shown), and a more dispersed distribution of infiltrating cells (Table 
1). The percentage of З/13-binding cells was significantly higher in 
non-demyelinating, compared to demyelinating infiltrations, while the 
difference in З/25-binding cells was not significant. In 
demyelinating lesions the few W3/13-labelled cells were often 
localized in the lesion center. 
TABLE 1 
Comparison of Two Different Types of "Late" Parenchymal Lesions. 
Demyelinating Non-demyelinating 
Lesions Lesions 
Mean Cell Concentration 0.6*(+0.3) 1.6*(±0.9) 
(leucocytes/um^) 
X W3/13 25**(±12) 57**(+9) 
X 43/25 A2 (±15) 56 (±10) 
Values are expressed as the mean percentage (±S.D.) of positively 
stained infiltrating cells from 15 lesions, averaging 23 cells, in a 
convalescent rat. 
* and **: significantly different. 
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Figure 1. The relative distribution of mononuclear cells labelled 
with MAbs among different CNS compartments and blood. 
The figure shows percentages of cells labelled with W3/13 (·), W3/25 
(Δ), 0X-8(o) and OX-3 (•) 
The mean spinal cord values shown (with standard deviations) are 
derived from the following cell quantities; meninges: 5 infiltrations 
averaging 60 cells from 2 rats; "early" parenchyma: 6 infiltrations 
averaging 20 cells from 2 rats; "late" parenchyma: 11 infiltrations 
averaging 45 cells from A rats. The derivation of the values for 
blood cells is described in the method section, as is the meaning of 
the terms "early" and "late".. 
DISCUSSION 
The quantification of the Τ cell markers in parenchymal tissue 
during the recovery stage of acute EAE, as reported in the present 
study, yielded comparable results to those of Hickey et al. (1983). 
Comparison with the values in other compartments and during disease 
onset however indicates a dynamic distribution of some lymphocyte 
markers. 
The differences in the extent of W3/13 binding between different 
compartments suggest a gradual decrease in the incidence of this 
epitope on individual Τ cells during their migration from the 
peripheral blood into the meninges and later into the parenchyma, 
since W3/25 binding does not decrease concomíttantly. This decrease 
apparently continued during the Τ cells' presence in the parenchyma, 
since fresh, non-demyelinating infiltrations showed only a slightly 
lower extent of V3/13 labeling compared to meninges, while 
established, demyelinating infiltrations displayed the lowest 
percentage of W3/13-binding cells observed in this study. 
Furthermore, most of the W3/13-labelled cells in the diffuse lesions 
were localized in its center (not shown), where blood cells enter the 
tissue (Lumsden, 1971). This phenomenon may reflect membrane 
differentiation during migration into the tissue and offers an 
explanation for the low degree of W3/13 binding in tissue 
infiltrations, as reported before (Hickey et al., 1983). In addition, 
a similar decrease in the incidence of the З/13-binding marker during 
culture has been reported before (Holda and Swanborg, 1982). As 
discussed later, OX-8 binding also declined in parenchymal tissue, but 
showed no correlation with the decrease in V3/13 binding in the 
meninges and therefore offers no full explanation for it, although a 
partial involvement has not been ruled out completely. In view of the 
gradual loss of the W3/13 markers from the surface of some Τ cells 
after infiltrating the CNS, the effect of W3/13 antibodies on the 
course of EAE (Brinkman et al, 1985) is likely to occur peripherally. 
Another more established example of membrane differentiation is 
the increase in la expression on mononuclear cells. The largest 
change observed in the present study occurred in blood during early 
EAE development, indicating an increased activity of the immune system 
(Unanue et al., 1984). 
A preponderance of helper Τ cells in the CNS parenchyma has been 
shown before in rats (Vekerle, 1984) and mice (Sriram et al., 1982; 
Hauser et al., 1984). In contrast to a decreased expression of the 
marker, as concluded from the W3/13-labelling results, differential 
cell distribution provides a better explanation for the observed 
difference in OX-8 binding between meninges and parenchyma. Birch et 
al. (1982) showed that during in vitro differentiation of Τ cells the 
suppressor phenotype increased rather than decreased at the expense of 
the helper phenotype in the Τ cell population. On the other hand, a 
decrease in CD8 density has been proposed to be involved in the drop 
of T
s / c cells in MS (Reder et al., 1984). 
A higher level of T
s
/ C in meninges compared to blood in guinea 
pigs (Traugott, 1983) and to parenchyma in rats (Meyermann et al., 
1985) and mice (Traugott et al.,1986) has been reported, and is 
interpreted as an accumulation of T
s
/ C in the meninges during acute 
EAE. In agreement with this interpretation is the observation that 
T
s/c cells in MS do not seem to migrate into CNS tissue as readily as 
Tg cells (Traugott et al., 1983). Instead, they possibly enter the 
parenchyma later, accounting for the increased OX-8 binding observed 
more than 50 days after immunization (Hickey and Gonatas, 1984). A 
recent report showing a lower proportion of CD8 cells in the CSF of MS 
patients during exacerbations also agrees with these results (Antonen 
et al., 1987). 
The meningeal accumulation of suppressor Τ cells in EAE presents 
a possible explanation for the differences in reported values of 
suppressor Τ cells in the CNS of MS patients, i.e., the ratio of Tg 
over T
s
/ C could be high in the parenchyma and low in the meninges. 
Furthermore, the low values for suppressor/cytotoxic Τ cells in 
parenchyma do not support the theory of enhanced cytotoxicity as a 
primary mechanism in disease development, nor do they present a likely 
source for the induction of recovery. However, a role for the 
meningeal T
s
/ C, abundantly present during recovery, cannot be ruled 
out. These considerations provide a factor in the theory concerning 
the changes in the ratio of the helper over suppressor Τ cells during 
the pathogenesis of EAE and possibly MS. 
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THE IMMUNOPATHOLOGY OF CHRONIC EXPERIMENTAL ALLERGIC 
ENCEPHALOMYELITIS INDUCED IN RABBITS WITH BOVINE PROTEOLIPID 
PROTEIN1 
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The role of myelin proteolipid apoprotein (PLP) in 
the central nervous system (CNS) immune response 
of rabbits has been investigated by analyzing the 
immunopathology of chronic experimental allergic 
encephalomyelitis (ЕАБ) induced by sensitization 
with PLP. Clinical disease occurred in seven out of 
nine rabbits sensitized with bovine PLP and moni­
tored for up to 6 mo. Positive delayed hypersensitiv­
ity skin test reactions to PLP occurred in all but one 
of the PLP-sensitized animals. All PLP-sensitized 
япітпяія had meningeal and CNS parenchymal in­
flammation that correlated with disease severity. 
Serial blood samples were stained with a panel of 
antibodies to rabbit Τ and В cells, as well as la. and 
large and small mononuclear cell populations were 
analyzed by flow cytometry. Peripheral leukocyte 
population staining did not correlate with clinical 
signs or sensitization to PLP. Cryostat CNS tissue 
sections were stained with the same set of anti­
bodies by using an immunoperoxidase technique, 
and positive cells and vessels were counted. Τ cells 
and macrophages were numerous and in equal num­
bers in perivascular parenchymal inflammatory in­
filtrates, whereas В cells were less numerous (p < 
0.001). Τ cells also diffusely infiltrated the paren­
chyma. Most perivascular inflammatory cells and 
many scattered parenchymal cells were Ia+; la vas­
cular expression was increased over controls (p < 
0.001), and also correlated with disease severity. 
The immunopathology of this chronic ЕАБ model is 
the same as that of whole CNS tissue- and myelin 
basic protein-induced EAE in other species, and is 
similar to that of multiple sclerosis. Cellular im­
mune responses to PLP may therefore contribute to 
systemic and in situ responses in CNS tissue demye-
Hnating diseases. 
Chronic experimental allergic encephalomyelitis 
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(EAE)3 Is a useful model of neuroautolmmune disease 
because It shares clinical, biochemical, immunologic, 
physiologic, and pathologic features with multiple scle­
rosis (MS) (1-3). Previous studies have shown that rabbits 
sensitized with bovine myelin proteolipid apoprotein 
(PLP) (for review see Reference 4) develop chronic pro­
gressive EAE (5. 6). Upon histopathologic analysis these 
animals exhibit perivascular inflammation ала demye-
lination, similar to that found In animals in which EAE 
is induced by sensitization with whole central nervous 
system (CNS) tissue or myelin basic protein (MBP) (7-10), 
or by adoptive transfer of sensitized cells (11. 12). The 
roles of the major myelin proteins MBP and PLP. and the 
possible modulating influences of other myelin compo­
nents in the immunopathogenetlc events of chronic EAE 
are incompletely understood (13-16). 
Circulating blood cell populations have been studied in 
animals with EAE because they are readily accessible 
and may provide clues to events occurring within the 
CNS (17-19). In contrast to small rodents (20). frequent 
blood sampling can be performed in rabbits during the 
disease course with less apparent risk of inducing alter­
ations In the disease, thereby permitting blood cell anal­
yses analogous to those performed in patients with MS 
(21-24). Furthermore, immunopathologic studies of CNS 
tissues from patients with MS (24-26) have shown pat­
terns of inflammatory cell infiltration and in situ la 
expression that are similar to those in chronic EAE (27). 
The nature of Inflammatory cells and patterns of In situ 
la expression in chronic EAE in rabbits induced by PLP 
sensitization have not been determined. Investigation of 
temporal dynamics and pathogenetic events occurring in 
blood and tissues in this chronic EAE model may lead to 
a better understanding of those that occur in MS. 
To define the in vivo and in situ immune response in 
chronic EAE Induced by PLP we 1) analyzed delayed 
hypersensitivity (DH) reactions to PLP during the course 
of the disease, 2) employed a panel of monoclonal and 
polyclonal antibodies to rabbit Τ and В cells and la to 
identify possible alterations In the peripheral blood 
mononuclear cell populations during the disease course, 
and 3) analyzed inflammatory infiltrates and la expres­
sion of vessels in CNS tissues by using routine histology 
and Immunohlstochemicai analysis with the same panel 
of antibodies. The results provide additional evidence for 
3
 Abbreviations used in this paper: CNS. central nervous system: DH, 
delayed hypersensitivity: EAE. experimental allergic encephalomyelitis. 
MBP. myelin basic protein: MS, multiple sclerosis; PI, postlmmunlzatlon: 
PLP, myelin proteolipid apoprotein. 
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a possible role of PLP In the pathogenesis of demyellnat-
Ing diseases. 
MATERIALS AND METHODS 
Antigen preparation. PLP was prepared from a washed total lipid 
extract of bovine white matter (28). Lipids were partially removed 
by emulslflcatlon and centrlfugatlon of the dried extract (29): the 
remaining lipids were removed by column chromatography on Seph-
adex LH60 and were eluted with chloroform-methanol-acetlc acid 2/ 
1/0.03 (v/v/v) (30). The apoprotein was then converted to a water 
soluble form by evaporation of the organic solvent In a stream of 
nitrogen and gradual replacement with water (29). The apoprotein 
thus obtained is devoid of detectable MBP (6, 31 ) and of lipid (<0.01 % 
lipid phosphorus). 
Animais. Eleven New Zealand White rabbits were obtained from 
ARI Breeding Labs. Avon. MA. Nine rabbits were sensitized with 1 
mg PLP in 0.5 ml Η,Ο emulsified with an equal volume of complete 
Freund's adjuvant (CFA) (Difco Laboratories. Detroit. MI) by multiple 
injections on the back (6). Two animals were injected with CFA 
alone. Animals were observed daily and weighed weekly. They were 
bled by ear vein puncture before and at intervals after sensitization 
(day 10 and upon change of clinical status), and by canllac exsan-
guinatlon at sacrifice. Clinical disease was graded on a scale from 0 
to 4 as follows: 0 » no clinical signs. 1 • ataxia. 2 " hind or forellmb 
paresis. 3 » hind or forellmb paralysis, 4 « limb paralysis plus 
Incontinence. The animals were periodically skin tested for DH to 
PLP and bovine serum albumin (BSA) by intradermal injections of 
100 ßg PLP or BSA In 0.1 ml water on shaved flank sites. Maximum 
diameters of erythema were measured 24 and 48 hr later. Reactions 
were considered positive when erythema of greater than 5 mm 
diameter and Induration were present. 
Monoclonal antibodies. Mouse monoclonal antibodies were gen-
erously provided by the Investigators Usted In Table I (32-37). Most 
were in the form of supematants from hybiidoma cells grown in 
tissue culture. Monoclonal antibodies 9AE10 and 2C4 were received 
as cells and were grown In RPMI with 20% fetal calf serum and 
antibiotics, and supematants were periodically harvested. For blood 
cell and tissue staining, the supematants were used undiluted. 
Monoclonal antibodies 31D2 and A6F10. previously used In Immu-
nohlstochemlcal studies (38. 39). were received as myeloma ascites. 
Staining dilutions are Usted in Table I. 
Analysis of blood cell populations. Antibody staining and flow 
cytometric analysis were performed according to Cosimi et al. (40). 
Blood samples (3 ml) were collected in heparinlzed tubes and were 
maintained at room temperature for no more than 1 hr. The tubes 
were centrlfuged at 1200 rpm for 5 min. The separated buff y coat 
was then Incubated for 5 min in lysing buffer (8.29 g NH,C1. 1.0 g 
КНСОз. 0.0372 g ethylene dlnltiilo-tetraaceUc add In 1 L HiO. pH 
7.3) to lyse residual red cells, and then was washed in phosphate-
buffered saline (PBS). The pellet was evenly divided among multiple 
glass tubes with 50 μΐ PBS each, and the samples were Incubated In 
an ice-water bath for 30 min with 50 μΐ monoclonal or polyclonal 
antibody. After washing, the samples were Incubated for 30 min 
with fluorescein-conjugated goat anti-mouse IgG (Tago. Inc., Burlln-
game. CA) or fluorescelnated rabbit anti-goat IgG (Cappel Laborato­
ries. Malvem. PA), each diluted 1/40 In PBS. when mouse mono­
clonal or goat polyclonal antibody were the primary antibodies. PBS 
controls (second antibody alone) were performed for each set of 
mouse and goat antibodies. After washing, the samples were sus­
pended In 1.2 ml cold PBS and were analyzed within 3 hr on the 
flow cytometer (Spectrum Ш: Ortho Diagnostics. Westwood. MA). 
Control blood samples from CFA-sensltlzed or unsensitlzed rabbits 
were always analyzed along with those from PLP-sensitlzed rabbits. 
Analysts of paraffin sections. At sacrifice. CNS tissues were 
removed and divided for cryostat and routine sections. After fixation 
in 10% formalin the cerebral hemispheres were sectioned coronally. 
and midbrain, brainstem, cerebellum, and spinal cord were sec­
tioned transversely, with alternate sections of brain and three levels 
of spinal cord processed routinely, embedded In paraffin, and stained 
with luxol fast blue-hematoxylln and eosln stain. 
Immunoperojcldose staining of cryostat sections. At sacrifice. 
representative sections of cerebrum, midbrain, brainstem, and three 
levels of spinal cord were embedded In OCT Compound (Lab-Tek 
Division, Miles Laboratories, Naperville, IL) and were frozen in a 
cryostat. Four micron sections were cut and stained with the anti­
bodies listed In Table I by using avtdln-blotln immunoperoxldase 
staining kits (Vector Laboratories. Burllngame. CA) for mouse and 
goat antibodies (38). In brief, slides were fixed In acetone and were 
incubated sequentially with normal horse (or rabbit) serum, primary 
antibody. Н3Ог blotlnylated horse anti-mouse (or rabbit anti-goat) 
Ig, and avldln-blotlnylated horseradish peroxidase complex with 
reaction product visualized with 3-amlno-ethyl carbazole and HiO,. 
The slides were then fixed in formol-acetate. counterstalned with 
hematoxylin, and mounted. Counts on paraffin and cryostat sections 
were performed without knowledge of the clinical status of the 
rabbits. In several animals. non-CNS tissues were also examined. 
RESULTS 
Clínícaí resuíts. The disease courses of the PLP/CFA-
sensltlzed rabbits are depicted in Figure 1. Rabbit no. 3 
was sacrificed on day 16 postlmmunizatlon (PI) and ex-
hibited no clinical signs. Rabbit no. 4 showed clinical 
signs on day 31 PI and was sacrificed shortly thereafter. 
Three more rabbits (nos. 5. 6. and 7) exhibited their first 
signs 36 to 48 days PI. These rabbits had similar rapidly 
progressive courses (ataxia of 8 to 13 days duration. 
severe paralysis within 23 to 50 days after onset of signs) 
and had to be sacrificed because of moribund conditions. 
Three other rabbits (nos. 8, 9. and 10) had signs that 
began later (83 to 104 days PI) and progressed slowly 
(ataxia of 30 to 48 days duration); these animals never 
became paralyzed. Two of them were sacrificed 5 mo PI 
and the third had only paresis up to 12 mo PI, but is 
presently deteriorating. One PLP/CFA-sensitlzed rabbit 
(no. 11) and the CFA-sensltized controls remained well 
throughout the experiment. 
Skin test reactions. DH skin test reaction results are 
shown in Table П. At 13 days PI. I.e., when no clinical 
disease was present, all rabbits showed little or no reac­
tion. Animals that subsequently became severely 111 (nos. 
TABLE I 
Antibodies 
Antibody (dilution 
if applicable) 
9AE10 
LI 1/135 
LI2/201C 
2C4 
31D2C( 1/200) 
A6F10 (1/100) 
Goat anti-rabbit M-chain* (1/100) 
Goat anti-factor ІП-related 
tlgen'll/SO) 
an-
Immunoglobulin Class 
(m.vr. of determinant 
recognized) 
IgM (25.000) 
IgGl (120.000) 
IgGl (not known) 
IgG2a 
28.000 (0) 
31.000(11) 
35.000 (a) 
Not known 
IgGl (110.000) 
Polyclonal antiserum 
Polyclonal antiserum 
Specificity 
Pan-T 
τ,τ," 
Τ,Τ,Β,Β,. null» 
la 
Guinea pig IgM 
Putative fibronectln receptor on 
macrophages 
В cells 
Endothelial cells 
Source* 
A 
В 
В 
A 
С 
D 
E 
F 
Reference 
(32. 33) 
(34. 35) 
(34. 35) 
(36) 
(37) 
" Monoclonal antibodies were gifts from: A. K. L. Knight. Chicago. IL; В. T. J. Kindt. Bethesda. MD: С E. M. Shevach. 
Bethesda. MD: and D. C. Blanco. New York. NY. Antisera were purchased from: E. Cappel Laboratories. West Chester, PA: 
and F. Atlantic Antibodies. Scarborough. ME. 
•T and В cell subset specificities defined by Jackson et al. (34). 
c
 Used for tissue studies only. 
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Figure l. Clinical counes of PLP-senaltlzed rabbits. Each shaded 
division Indicates an increase In clinical score, with termination of the 
bars Indicating the times of sacrifice. Animals are arranged and num­
bered according to their disease patterns. CFA-sensltlzed rabbits were 
sacrificed on days 160 and 294 PI. 
TABLE Π 
Skin tests In PW-senslttzed rabbits 
Rabbit 
Numoer 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Days И 
13 
13 
33 
13 
58 
43 
58 
43 
122 
138 
122 
122 
13 
138 
Score 
at Time 
of Test 
0 
0 
1 
0 
2 
1 
2 
1 
1 
2 
2 
1 
0 
0 
Reaction (mm) at 
24 hi* 
_ 
— 
9+ 
4 
6+ 
9 
10+ 
9 
9 
a 9 
7 
— 
9 
4β hr* 
5+ 
— 
9+ 
4 
10+ 
7+ 
10+ 
9+ 
— 
7 
9+ 
θ 
— 
9 
* Numbers Indicate maximum diameter (mm) of erythema of PLP skin 
test reactions: + Indicates reactions with a white center and -- indicates 
negative reactions. 
5. 6, and 7) and rabbit no. 4 showed strongly positive 
reactions at the first appearance of clinical signs. Ani­
mals in which the disease developed later and remained 
mild showed less consistently positive reactions. All PLP-
sensitlzed rabbits, but not the CFA controls, exhibited 
positive DH reactions during the experiment, except rab­
bit no. 3. which was sacrificed early. Reactions to BS A 
were usually erythematous after 24 hr but disappeared 
thereafter. 
Peripheral blood mononuclear cell populations. Two 
cell populations were analyzed in each buf fy coat sample. 
Table ΠΙ shows the staining results grouped according to 
the clinical score of the animals at the time of sampling. 
Controls were either CFA-sensitlzed rabbits or experi­
mental rabbits sampled before sensitization. The propor­
tions of cells in the small mononuclear cell population 
that stained with the two anti-T cell antibodies were 
similar In all groups. However, more cells In the large 
mononuclear cell population stained with LI 1/135 than 
with 9AE10. Longitudinal analyses of Individual rabbits 
suggested that there were more la* small mononuclear 
cells In rabbits with scores of 2 to 4 than In less severely 
diseased or control animals. There was also a tendency 
for Τ cells to Increase after sensitization with PLP and to 
decrease as the disease progressed. However, large vari­
ations among animals and at different times of sampling 
prevented the demonstration of conclusive differences in 
the proportions of stained circulating blood cell popula­
tions among the animal groups. 
friflammatory infiltrates. Perivascular mononuclear 
cell infiltrates and demyelination, which were typical of 
chronic EAE. were observed (Fig. 2). Inflammatory cells 
were quantltated in paraffin sections of CNS tissues (Fig. 
3). All PLP-sensltlzed rabbits exhibited histologic disease. 
The degree of Inflammation generally correlated well 
with the severity of clinical disease, although rabbit no. 
4. which was sacrificed Immediately after the onset of 
mild signs, exhibited florid histologic disease. The 
amount of meningeal inflammation also closely corre­
lated with that in the CNS parenchyma. 
Characterization of inflammatory infiltrates. In Ini­
tial testing, only rare cells stained with 9AE10 and antl-
μ-chaln antibody in normal rabbit liver, kidney, heart, 
lung, testis, bladder, and shaved skin. There were abun­
dant Τ cells in periarteriolar lymphatic sheaths and many 
scattered В cells in the spleen: most spleen cells were 
weakly la*, predominantly in non-T cell areas. There 
were many la* cells In the liver (Küpffer cells) and scat-
tered in other tissues, whereas vascular endothelial cells 
were predominantly la". In normal rabbit CNS tissues 
there were only rare scattered Τ and μ* cells, and no 
cross-reactlvitles of any of the antibodies with CNS pa­
renchymal components were found. 
9AE10* and LI 1/135+ Τ cells were most numerous in 
meningeal and parenchymal inflammatory Infiltrates in 
CNS tissues of rabbits with EAE (Fig. 4A). A6F10* mac­
rophages stained less intensely than in other species (39), 
but positively stained cells were readily identifiable. 
31D2* or goat anU-μ* В cells were less numerous than 
either Τ cells or macrophages (Fig. 4B). In sections 
stained with the anti-lymphocyte antibody LI2/201, 
slightly larger numbers of cells were stained. Τ cells also 
diffusely infiltrated the CNS parenchyma in areas away 
from perivascular inflammatory cell aggregates (Flg. 4C), 
whereas macrophages and В cells were confined to peri­
vascular foci. 
Quantitative data on the composition of the inflam­
matory infiltrates from a control and three PLP-sensi-
tlzed rabbits are shown In Figure 5. Virtually no Inflam­
matory cells were found in controls. In each of the sen­
sitized rabbits, regardless of the disease state, the com­
position was the same. Τ cells and macrophages were 
present in nearly equal numbers, and both were more 
numerous than В cells In each animal (p < 0.001 by 
Student's t-test). Quantitation of cells stained with the 
other lymphocyte markers gave patterns that were more 
variable, but were consistent with their putative specific­
ities. 
In situ la expression. Most perivascular parenchymal 
and meningeal inflammatory cells were la* and there 
were scattered la* cells In the parenchyma (Flg. 6A). The 
individual Identities of these cells could not be deter­
mined in the cryostat sections. Many appeared to be 
localized to the periphery of perivascular inflammatory 
aggregates. Only rare endothelial cells and no other CNS 
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TABLE Ш 
Analysis of mononuclear blood cell populations* 
AnUbody 
(specificity) 
Small mononuclear 
cells 
9AE10(T) 
LI 1/135 (T) 
2C4 (la) 
Large mononuclear 
cells 
9AE10(T) 
L11/135(T) 
2C4 (la) 
Unsensitized 
and CFA 
27 2 ± 2.4(10) 
35 4 ± 7 6 (4) 
49 4 ± 4 6(18) 
41 I ± 8 0 (8) 
60 7 ± 16 8 (3) 
47 2 ± 5.5(13) 
56 9 ± 
55 8 ± 
52.6 ± 
45 3 ± 
87 8 ± 
6 4 0 ± 
J 
3 6(5) 
12 6 (6) 
5 3(6) 
4 7(4) 
3 3(3) 
8 2(4) 
PLP-Seiultlzed Animala 
Clinical Score at 
Time of Sampling 
1 
41 9 ± 3 3(5) 
48 9 ± 3 1 (4) 
41 4 ± 7 0(4) 
43 4 ± 7 1 (4) 
92 3 ± 3 8 (4) 
56 7 ± 9 7 (4) 
2-4 
38 4 ± 3 4(7) 
46 4 ± 6 7 (η 
66 7 ± 6 7(7) 
27 0 ± 10 2 (4) 
59 1 ± 13.5 (4) 
64 2 ± 13 3(5) 
" The scatter patterns of leukocyte populations for control and chronic EAE animals were similar to those In other 
species, and two cell populations. I e . small and large mononuclear cells, were selected for analysis Data from the flow 
cytometer are reported as percentages of stained cells within the selected populations minus the percentage of positive 
cells In PBS control samples Data are tabulated as mean ± SEM (number of samples) The range of cells used for data 
analysis was between 500 and 100.000 per antibody sample 
Figure 2. A Perivascular mononuclear cell Inflammation and demyellnatlon (аггошз) In the anterior spinal cord of rabbit no 5 Luxol fast blue-
hematoxylln and eosin x79 В Higher power showing llpld-laden macrophages and reactive astrocytes (arrouiheads) In focus of subplal demyellnatlon. 
X200 С Olfactory tract of rabbit no 5 stained with Weigert stain for demonstration of demyellnatlon (pale areas). x50 
with inflammation (Flg. 6B). Only 4% of factor VIII-re-
lated. antigen-positive vessels were la* In the controls. 
and this increased to approximately 80% in PLP-sensi-
tlzed animals. The degree of vascular la expression gen­
erally correlated with the degree of Inflammation and 
severity of clinical disease (Flg. 7). 
DISCUSSION 
PLP-induced chronic EAE in rabbits has several fea­
tures that make it particularly useful as a model of neu-
roautoimmune disease. Unlike other chronic EAE 
models, there Is no acute phase of clinical disease, and a 
spectrum of severity with relapses and remissions may 
occur (5. 6). Variability in clinical manifestations Is also 
an important and frequently complicating aspect of MS 
(41). In this study, we observed two distinct clinical dis­
ease patterns, i.e.. inexorably progressive disease culmi­
nating in severe neurologic deficits and a more chronic, 
less debilitating form with longer periods of stable neu­
rologic function. Different immunogenetic susceptibili­
ties to PLP antigenic determinants in these outbred ani­
mals might contribute to the variable patterns of clinical 
CNS IRFUiNATION IN MÍAFFIH SECTIONS 
| І И І І І Ц І І Н І С І 
PiriickTuI (Ml 
Figure 3 Quantitation of inflammation and Its relation to the severity 
of clinical disease Foci of inflammation (>20 inflammatory cells sur­
rounding vessels) In medium power fields (field radius =• 460 дт) were 
counted In meninges and parenchyma for each anatomic level (38) 
parenchymal cells were unequivocally Ia+ in control rab­
bits. The numbers of la* vessels Increased in animals 
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Figure 4. A. Perivascular Τ cells In Inflammatory Infiltrate In spinal 
cord of rabbit no. 4. Monoclonal antibody 1.11/135. Immunoperoxldase 
with hematoxylin: x200. Inset. x50O. В. В cells (arrouiheads) In Inflam­
matory Infiltrate In spinal cord of rabbit no. 4 stained with polyclonal 
goat antl-μ immunoperoxldase with hematoxylin: хЗІЗ. С Diffusely In­
filtrating Τ cells (arrouiheads) In parenchyma of rabbit no. 9 spinal cord. 
Monoclonal antibody 9AE10. Immunoperoxldase with hematoxylin: 
X500. 
disease expression (42. 43). Indeed, different susceptibil­
ities to MBP peptides have been documented In several 
species (12. 44. 45). and these susceptibilities have been 
linked to major histocompatibility complex gene expres­
sion In Inbred mice (44) and guinea pigs (12). 
Essentially all PLP-sensltlzed animals developed posi­
tive skin tests to PLP. and all had some CNS inflamma-
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Figure 5. Quantltatlon of cellular composition of perivascular inflam­
matory Infiltrates in four rabbits. The proportions of stained cells per 
total nuclei per high power field (field radius - 230 дш) were counted in 
all CNS levels. The same proportions of stained cells were found In 
sections stained with L11 /135 and 9AE10. and with polyclonal goat anti-
rabbit μ-chaln and 31D2: the results were therefore combined for data 
analysis of Τ and В cells respectively. The control rabbit exhibited no 
signs. Rabbit no. 4 had mild signs, was sacrificed early, and had abundant 
CNS Inflammation. Rabbit no. 5 had severe clinical and pathologic dis­
ease. Rabbit no. 8 had mild disease and was sacrificed late in the disease 
course. В » goat anti-M-chaln plus 31D2: Τ = 9AE10 + LI 1/135: Τ + В + 
null - LI2/201: macrophages - A6F10. 
tlon. However, cellular immunity to PLP determinants 
was not sufficient to account for the spectrum of clinical 
disease. DH reactivity to PLP may be necessary for the 
development of disease, but additional factors may mod­
ulate Its clinical expression. DH reactions incompletely 
correlate with clinical and histologic parameters In 
chronic EAE in guinea pigs (46). In a previous study. 
spinal cord-sensitized guinea pigs that developed EAE 
had in vitro proliferative responses to peritoneal exudate 
cells to MBP, but not to PLP, whereas PLP-sensltlzed 
animals did show proliferative responses to PLP (13). 
Epitopes exposed in myelin may differ from those in the 
Isolated PLP (Lin and Lees, unpublished observations), 
and this may in part explain differences between whole 
CNS tissue and Individual myelin components. Further­
more. complex interactions may occur among multiple 
myelin antigens. Including cerebrosides and gangliosldes 
(14-16). These may contribute to and modify cellular and 
humoral immune responses in whole CNS tlssue-sensi-
tlzed animals, and by analogy, in patients with MS. 
In contrast to studies of MS (21-24) and EAE In the 
mouse (19), we detected no consistent alterations in blood 
Τ cell, В cell, or la* cell populations during the disease 
course. The data suggest possible Increases in circulating 
Τ cells after sensitization, with subsequent decreases In 
the course of the disease and a tendency for increased 
numbers of circulating Ia+ cells as the disease progresses. 
However, monoclonal antibodies to specific functionally 
relevant Τ cell subsets (47) were not available at the time 
of this study, and the results may have been more strik­
ing in Τ cell subset populations in the blood. 
With the exception of rabbit no. 4. the severity of 
clinical disease correlated with the numbers of inflam­
matory infiltrates in CNS paraffin sections. This Is ad­
ditional evidence that the in situ Immune response to 
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Figure 6. Λ. Perivascular and diffusely distributed la* cells In spinal 
cord of rabbit no. 4. Monoclonal antibody 2C4 with hematoxylin; x200. 
B. la* endothelial and other parenchymal cells (аглош/iecuís) In brainstem 
of rabbit no. 5. Monoclonal antibody 2C4 with hematoxylin: xSOO. 
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Figure 7. Quantitation of blood vessels stained with anti-rabbit la 
antibody. 
PLP directly contributes to the pathogenesis of disease In 
this model. The cellular composition of perivascular in­
flammatory Infiltrates and patterns of diffuse Τ cell in­
filtration of the parenchyma are also very similar to those 
EAE IN RABBITS INDUCED BY PLP 
In acute and chronic EAE Induced in other species with 
whole CNS üssue or MBP sensitization (19, 27, 38), and 
to those reported in MS (24-26). This infiltration pattern 
is consistent with direct Τ cell effects on myelin over a 
wide area of parenchyma. 
As in other models, we found diffusely scattered Ia+ 
parenchymal cells and a marked Increase over normally 
low numbers of la* vessels in PLP-sensltized animals. In 
guinea pigs, exhaustive perfusion did not alter la cellular 
or vascular expression, suggesting that the Identified la 
was strongly bound in the tissues (48). The greatest con­
centration of parenchymal la* cells was in areas adjacent 
to vessels with perivascular infiltrates (Flg. 6A), suggest­
ing that some of the la* cells might be Τ cells that were 
migrating outward from vessels, or that la was Induced 
locally by soluble factors, e.g., interferon-^ or other lym-
phokines that originated In the inflammatory focus. As­
trocytes (49) and CNS endothelial cells (50) have recently 
been shown to function as antigen-presenting cells for 
myelin antigens in vitro and have also been shown to 
express la antigens In situ in EAE (51. 52). As In guinea 
pigs and rabbits, class Π МНС molecules are low in en­
dothelial cells in normal human CNS (53, 54). la* vessels 
are, however, prominent in the brains of patients with 
MS (24. 25), suggesting that modulation of la expression 
occurs along with mononuclear cell inflammation In MS. 
These observations, therefore, also support Immunologic 
roles for endothelial and possibly other CNS parenchymal 
cells In situ. 
In summary, sensitization of rabbits with PLP alone 
produces Immune responses and a disease that is clini­
cally and immunopathologically similar to chronic EAE 
in rabbits and other species, and that shares some im­
portant features with MS. Genetically determined im­
mune responses to different CNS antigens may vary in 
time and magnitude among individuals and may influ­
ence disease severity. Dissection of the responses to PLP 
and other CNS antigens in EAE may contribute to a better 
understanding of the pathogenesis and variability in clin­
ical expression of human demyelinating diseases. 
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Summary 
A chronic form of experimental allergic encephalomyelitis can be produced by 
sensitization of rabbits with bovine myelin proteolipid apoprotein (PLP). To in­
vestigate the humoral immune response in this model, serum PLP antibodies were 
determined by enzyme-linked immunosorbent and dot immunobinding assays. In an 
initial experiment, 3 PLP-sensitized rabbits with severe chronic experimental allergic 
encephalomyelitis had a positive antibody response whereas 3 with mild disease, or 
with no visible clinical disease, had no detectable antibodies against PLP. In a 
second experiment, 3 rabbits were preimmunized with PLP in incomplete Freund's 
adjuvant, followed by a single immunization with PLP in complete Freund's 
adjuvant. These animals developed chronic experimental allergic encephalomyelitis 
with different progression rates, although all eventually became severely paralyzed. 
In both experiments the anti-PLP response was maximal before or immediately after 
disease onset and tended to decline during disease progression. The degree of the 
anti-PLP response correlated with clinical and histologic disease severity. These data 
suggest a possible role for humoral factors in the modulation of the chronic EAE 
induced in PLP-immunized rabbits. 
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Introduction 
Experimental allergic encephalomyelitis (EAE) has been studied extensively as a 
model for the clinical, histopathologic and immunologic events occurring in multiple 
sclerosis (Alvord et al. 1984). Initial studies were directed to the acute form of the 
disease produced by immunization of various animal species with either whole CNS 
tissue, myelin or myelin basic protein. More recent efforts have emphasized a 
chronic model in which animals that survive the acute EAE attack subsequently 
recover and often go on to have one or more relapses. In both acute and chronic 
EAE, myelin basic protein (MBP) is recognized as the major encephalitogenic 
protein of CNS tissue. However, other components have also been implicated either 
as modulating factors or for the initiation of demyelination (Brosnan et al. 1983: 
Tabira and Endoh 1985). 
Myelin proteolipid protein (PLP) is quantitatively the major protein of CNS 
myelin (see Lees and Brostoff 1984 for review). In the 1950s, it was shown that a 
mild form of EAE could be induced in rabbits, guinea pigs and mice immunized 
with a lipid mixture containing PLP (Olitsky and Tal 1952; Goldstein et al. 1953: 
Waksman et al. 1954). Current methodology allows the isolation of the proteolipid 
apoprotein free of non-covalently bound lipids and ьепыіі е chemical and immuno­
logical techniques have demonstrated that the apoprotein is free of detectable MBP 
contamination (Cambi and Lees 1985). This preparation has been shown to induce a 
chronic EAE in rabbits with many features comparable to those seen in other species 
immunized 'with whole CNS tissue (Williams et al. 1982; Cambi et al. 1983). 
However, in contrast to other models which are characterized by an initial acute 
phase, immunization with PLP gives rise only to a chronic progressive or relapsing 
disease with a relatively late onset. 
We have recently described the immunopathologic characteristics of the cellular 
responses of rabbits immunized with PLP and have shown their similarity to those 
observed after immunization with whole CNS tissue or MBP (Sobel et al. 1986). In 
the present paper, we report the results of studies on the humoral immune response 
to PLP. Using two different protocols, a relationship was observed between the 
serum antibody response to PLP and disease severity. 
Materials and Methods 
Antigen preparation 
PLP was prepared from a washed total lipid extract of bovine white matter (Folch 
et al. 1957). To obtain the apoprotein, lipids were partially removed by emulsifica-
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tion and centnfugation followed by removal of the remaining lipids on a Sephadex 
LH-60 column (Bizzozero et al. 1982). The chloroform-methanol-soluble apoprotein 
was then converted to the water-soluble form by evaporation of the organic solvent 
in a stream of nitrogen with gradual replacement with water (Lees and Sakura 1979). 
Sensitization of animals and clinical observations 
In the first expenment, 9 New Zealand/White rabbits (ARI, Avon. MA) were 
sensitized intradermally at multiple sites along the flank with an emulsion consisting 
of 1 mg PLP in 0.5 ml water and an equal volume of complete Freund's adjuvant 
(CFA) containing 0 5 mg/ml Mvcobactenum butyricum (Difco, Detroit, MI) Two 
control rabbits were injected with an emulsion of water and CFA. Animals were 
bled by ear vein puncture before and at intervals after sensitization and observed 
and weighed 2-3 times a week. 
In a second expenment, 3 rabbits were preimmunized 5 times over a 3-week 
penod with 0.1 mg PLP in 0 1 ml water emulsified with an equal volume of 
incomplete Freund's adjuvant (IFA) Subsequently, the animals were sensitized with 
a single dose of 1 mg PLP in 0.5 ml water emulsified with an equal volume of CFA 
containing both M butyricum (0.5 mg/ml) and M tuberculosis (10 mg/ml) Clinical 
disease was graded as follows. 0 =» no clinical disease. 1 =° ataxia. 2 = hind limb 
paresis, 3 » hind limb paralysis. 4 = paralysis plus incontinence. The animals were 
sacrificed and CNS tissues analyzed as previously described (Sobel et al 1986). 
Humoral antibody analysis 
Antibody titers against PLP and MBP were determined by an enzvme-linked 
immunosorbent assay (ELISA) (Macklin and Lees 1982) In brief, PLP or MBP was 
bound to microliter plates, the plates rinsed, incubated in triplicate with test or 
preimmune sera diluted in phosphate-buffered saline, pH 7 3 containing 0 1^ Tween 
20 and then nnsed again. Plates were subsequently incubated with horseradish 
peroxidase-conjugated goat anti-rabbit IgG containing 1% BSA and, after nnsing, 
o-phenylenediamine in citrate-phosphate buffer containing HiCK was added. The 
reaction was stopped by addition of citnc acid and quantitated by absorbance at 454 
nm in a Bio-Тек model EL 307 ELISA reader. 
Antibodies were also identified by a modification of the dot immunobinding 
method of Lebar and Lees (1985). Bnefly, 1 μΐ aliquots of the aqueous form of PLP 
were spotted on nitrocellulose stnps Non-specific antibody binding was blocked by 
incubation for 45 mm at 370C in 0 01 M Tns-NaCl buffer (pH 7.4) containing 3% 
BSA. Stnps were nnsed and incubated overnight at room temperature with test 
serum diluted 1.200 with the above buffer containing 10% normal goat serum. After 
washing, stnps were incubated in 2 ml horseradish peroxidase-conjugated goat 
anti-rabbit IgG, diluted 1 5000 in the same buffer as the first incubation After 2 h, 
the stnps were washed and the antigen-antibody complexes visualized with 1 mg/ml 
diaminobenzidine in 0.1% imidazole containing 1 μΐ/ml 30% H^O, For quantita­
tion, dots were scanned in a Hoefer model GS 300 densitometer. 
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ISO 180 200 
Fig. 1 Oimcal counes of selected PLP-immumzed rabbits (first expenment). Shaded areas represent 
clinical scores. Animals are grouped according to disease seventy Mean weights and ranges are plotted 
for each group. Mild disease · · ; severe disease О О Rabbit No. 10 remained stable for 
over 10 months p.i. and then began to detenorate. All other animals were sacnficed at the time indicated 
by the bar at the end of the shaded area. 
TABLE 1 
ANALYSIS OF SERUM ANTI-PLP ANTIBODIES BY ELISA 
Rabbit 
number 
5 
6 
7 
8 
9 
10 
3" 
4 b 
Days 
p.i. 
56 
107 
36 
43 
71 
43 
113 
80 
143 
130 
143 
107 
17 
38 
Clinical score 
on day of 
bleeding 
0 
1 
ELISAJ 
OD 
x l O 3 
88 
68 
150 
130 
12 
41 
39 
— 
— 
4 
-
81 
Range 
75-100 
34-106 
101-198 
123-137 
0-35 
19-63 
30-47 
0-7 
η 
* Pre-immune sera from each rabbit were assayed at the same time as the expenmental sera. Values 
correspond to optical density readings of expenmental minus preimmune sera and are expressed as the 
mean of η assays each of which was earned out in triplicate Negative results are indicated as - CFA 
controls had no anti-PLP antibodies 
h
 Sacnficed at an early stage. 
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Results 
Of the 9 rabbits immunized with PLP in the first experiment, rabbits No. 3 and 4 
were sacrificed at an early stage, 10 and 38 days postimmunization (p.i.), respec­
tively. One PLP-immunized rabbit (rabbit No. 11) remained free of clinical signs and 
was sacrificed 140 days p.i. The remaining 6 animals could be divided into 2 groups 
based on their disease course (Fig. 1). One group (rabbits No. 5, 6 and 7) showed an 
early disease onset (36-48 days p.i.), marked weight loss and rapid progression to 
severe disease. These animals were ataxic for only 8-13 days before paresis became 
obvious. They were sacrificed between 2 and 4 months p.i. because of their 
moribund conditions. The other animals (rabbits No. 8, 9 and 10) had a later disease 
onset (83-104 days p.i.) and a milder course. They showed no weight loss, ataxia was 
evident for 30-48 days and they did not progress to paralysis. The CFA-sensitized 
controls remained normal. Histological and immunopathologic observations on the 
animals from this experiment have been reported (Sobel et al. 1986); a correlation 
was observed between histological and clinical disease. 
DAYS PI 
Fig. 2. Dot immunobinding assay for PLP antibodies in serum samples from rabbit No. 6. PLP 
concentrations dotted, from left to right, are 500. 200, 100, 4 and 0.8 μg/ml. PI. postimmunization. 
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Fig. 3. Typical dilution curves of serum samples from rabbit No. 19 analyzed by an ELISA for PLP 
antibodies. Sera were taken at (he following days p.i.: 17 days A, 45 days O; 62 days •: 131 days O. 
Arrows indicate the serum titer, defined as the last dilution to show a decrease of > 0.05 optical density 
units compared with the previous dilutions. Disease onset was 55 days p.i. 
The ELISA analyses on sera from these animals are shown in Table 1. Each of the 
severely ill animals showed positive humoral anti-PLP responses. In contrast, all sera 
from the mildly ill group were negative for antibodies against PLP at all time points 
tested. These observations on the presence of anti-PLP antibodies were essentially 
confirmed by the dot immunobinding assay. Data on multiple bleedings of a 
representative animal (rabbit No. 6) are shown in Fig. 2. No antibodies against MBP 
were detected by ELISA at any time in any of the sera. 
The initial purpose of the second experiment was to induce a high titer of 
anti-PLP antibodies. The experiment was therefore carried out using a hyperim-
munization protocol comparable to that used to obtain antibodies against MBP 
(Driscoll et al. 1974). Under these conditions no EAE was expected to develop. A 
strong anti-PLP response was indeed obtained, but contrary to expectations, the 3 
animals began to develop clinical EAE 45-99 days p.i. with typical chronic progres­
sive courses. ELISA analyses were performed on serial dilutions from sequential 
bleedings and used to determine serum antibody titers as shown in Fig. 3. As 
determined by both the ELISA and the immunodot assay, the humoral anti-PLP 
response in each animal reached a maximum just prior to or shortly after disease 
onset and decreased as the severity of the disease progressed (Figs. 3 and 4). The 
titer at approximately 30 days p.i. correlated with subsequent disease course, i.e. was 
highest in the rabbit that developed severe disease earliest, and lowest in the rabbit 
showing delayed disease development. Tests for the presence of MBP antibodies 
were negative in this experiment, as in the previous experiment. 
327 
ι 1000 
I 10000 
ζ g 
I -
О 
2 
(Г 
ш 
to 1100 
I ІОООО 
4 
n¿b яммі # i r 
¡I 
4 — 
ω 
- « 
- 4 
DAYS PI 
Fig. 4. Antibody response to PLP and clinical course of PLP-hypenmmunized rabbits (second experi­
ment). Shaded areas represent clinical scores. Results from ELISAs O. expressed as the mean of 2 or 
more titers (as defined in Fig. 3). Immunobinding data · . expressed as the height of the peaks in the 
densitometer tracings. Antigen concentration 0.1 mg/ml; serum dilution 1.800. 
TABLE 2 
QUANTITATION OF INFLAMMATORY FOCI IN PLP-HYPERIMMUNIZED RABBITS 
Values represent number of foci ( > 20 inflammatory cells) counted over the entire areas of standard 
cerebrum, midbrain, brainstem, cervical, thoracic and lumbosacral spinal cord sections. Foci were counted 
as described in Sobel et al. (1984). 
Meningeal 
foci 
Parenchymal 
foci 
Total 
Rabbit No 18 
Rabbit No. 19 
Rabbit No. 17 
80 
66 
18 
80 
52 
9 
160 
118 
27 
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Meningeal and parenchymal chronic inflammation and demyelination were ob-
served at autopsy in all 3 animals. The numbers of inflammatory foci correlated with 
time of onset of clinical disease (Table 2) and the extent of demyelination generally 
paralleled the amount of inflammation. Rabbit No. 17 with the least inflammation 
had only mild subpial demyelination. mostly in the spinal cord (Fig. 5A) whereas the 
other rabbits had more extensive inflammation and perivascular and parenchymal 
demyelination in both the brain and spinal cord (Fig. 5B, C). 
Fig. 5. Light microscopy of CNS lesions in PLP-immunized rabbits. A: Subpial demyelination (arrows) in 
spinal cord of rabbit No. 17, Weigert myelin stain, 79 X. B: Marked meningeal and parenchymal 
inflammation in olfactory tract of rabbit No. 18, luxol fast blue-hematoxylin and eosm stain, 200 x . 
C: Subpial demyelination (arrows) and meningeal inflammation in spinal cord of rabbit No. 19. Weigert 
myelin stain, 313 x . 
в 
Fig. 5 В. С. 
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Discussion 
A cell-mediated response is known to be involved in EAE but the role of humoral 
factors, and specifically antibodies, is less clear. We have already charactenzed the 
cellular immune response in the PLP-immumzed rabbits from the first expenment of 
the present study and have shown a correlation between the Τ cell response and 
clinical disease (Sobel et al. 1986). The current study describes the antibody response 
to PLP not only in that group of rabbits but also in ал additional set of animals. The 
data from the initial expenment in the present study suggested a positive correlation 
between the serum antibody response against PLP and the disease course and this 
was supported by the results of the second expenment. Peak antibody titers were 
present at the tune when clinical symptoms could first be detected and a decrease in 
anti-PLP titers was noted as the disease progressed. The cause of the decrease is 
unknown but could be related to decreased antibody production, sequestration in 
the CNS or interaction with circulating PLP or PLP-like fragments. The last 
possibility is suggested by the appearance of PLP-reactive matenal in CSF and 
serum of patients with active demyelinating disease (Trotter et al. 1983). Although in 
an earlier report we had concluded that there was no correlation between antibody 
titers to PLP and the clinical course of disease (Cambi et al. 1983), a wider spectrum 
of clinical disease was observed among the rabbits in the present study and 
antibodies to PLP, when detectable, showed higher titers. These factors, together 
with more frequent bleedings, permitted a more extensive analysis. 
The presence of an anti-PLP response in the early phase of severe EAE as 
opposed to its absence in the early phase of mild disease, points to a possible 
prognostic value of the PLP antibody response. Thus, rabbit No. 4, which was 
sacnficed at 38 days p.i. shortly after disease onset, showed a positive anti-PLP 
response and was apparently developing severe disease. This conclusion is supported 
by the early onset of clinical signs and the marked CNS inflammation observed in 
this animal (Sobel et al. 1986). Recently, Yoshimura et al. (1985) reponed a 
correlation between anti-PLP antibodies and disease activity in chronic EAE in­
duced by PLP in Hartley guinea pigs. The effects of PLP thus differ from those of 
MBP since several groups have found no correlation between serum antibodies to 
MBP and clinical disease (Lassmann et al. 1984; Schwerer et al. 1984; Tabira and 
Endoh 1985). 
A striking observation is that, in contrast to MBP, preimmunization with PLP in 
IFA under the conditions tested, does not protect against subsequent challenge with 
PLP in CFA. Preimmunization with MBP in IFA results in high MBP antibody 
titers that may or may not be involved in protection against EAE induction (Lisak et 
al. 1970; Dnscoll 1974). Furthermore, it leads to decreased cell-mediated immunity 
(Lisak et al. 1980). Preimmunization with PLP also results in higher specific 
antibody levels. However, a cell-mediated response is evident histologically within 
the CNS. Clinically, the difference between the MBP- and PLP-induced models is 
that, in the former, an acute response is observed whereas in the latter only the 
chronic phase can be detected. It thus appears that the protective effects observed in 
the MBP model may be directed to factors that mediate the acute attack and that 
these are not operative in the PLP-induced model. 
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PLP and MBP differ in their biochemical properties (see Lees and Brostoff 1984 
for review) and this may be reflected in the above-descnbed immunologic effects. 
MBP is easily degraded enzymatically whereas proteolytic cleavage of PLP is 
difficult to achieve. If fragments denved from endogenous proteolytic breakdown of 
myelin have any role in the initiation of the disease process, a rapid release of MBP 
and a slow release of PLP would in part explain the absence of acute disease in the 
PLP-immunized animals. Furthermore, whereas MBP is an extrinsic protem associ-
ated with the cytoplasmic face of the myelin membrane, PLP is a hydrophobic 
protein that spans the lipid bilayer and is probably partially exposed on both the 
cytoplasmic and the external membrane faces (Laursen et al. 1984). 
The data reported previously (Sobel et al. 1986) and in this paper, demonstrate 
that both humoral and cellular immune responses appear to correlate with the 
disease course in rabbits challenged with PLP. PLP antibodies alone are presumably 
not sufficient for disease induction but might enhance the effects of the cellular 
immune response. To understand the pathophysiology of the PLP-induced disease, 
an important question is whether anti-PLP antibodies are demyelinating. Antibodies 
against PLP isolated from SDS gels do not demyelinate bram tissue expiants (Seil 
and Agrawal 1980). However, the topography of the protein in myelin may differ 
from its conformation in SDS and selected domains outside the bilayer may be 
important in demyelination (Lees et al. 1984). Antibodies to M2, an unidentified 
myelin antigen that shares certain properties with PLP, are demyelinating (Lebar et 
al. 1979). Our preliminary evidence indicates that immunization of rabbits with a 
peptide denved from chemical cleavage of PLP or with a synthetic peptide denved 
from the PLP sequence also results in a chronic EAE with marked demyelination. 
Thus, the possibility remains that antibodies to specific preparations or regions of 
the PLP may be involved in demyelination. MBP produces mainly an inflammatory 
response with little or no demyelination (Raine et al. 1981) and antibodies against 
MBP do not demyelinate in vivo or in vitro (Seil et al. 1968; Fry et al. 1974; Brosnan 
et al. 1983). 
The immunologie responses to challenge with whole CNS tissue are complex and 
interdependent, as they are in multiple sclerosis, and cannot be explained by a single 
factor. PLP and MBP provide EAE models that, in some respects, are complemen-
tary, i.e., taken m combination, they would essentially account for the features of 
CNS-induced EAE. A better understanding of the immunologic effects of the 
purified components will therefore clanfy the response of animals to challenge with 
whole CNS tissue. An evaluation of anti-PLP serum antibodies in multiple sclerosis 
patients will be required to assess the applicability of the findings of this study to 
human disease. 
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The effect of myelin basic protein on the protease 
inhibitors alpha! antitrypsin and alpha2macroglobulin 
R С van der Veen, С J J. Brinkman, 
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Radboud University Hospital Nijmegen, 
The Netherlands 
ABSTRACT - The effect of myelin basic protein (MBP) of central nervous tissue on 
the protease inhibitors, alpha) antitrypsin (aι AT) and alpha;macroglobulm (агМ) was 
studied (л vitro For this purpose. 2 characteristics of the protease inhibitors were used, 
viz their pattern after isoelectric focusing and their trypsm-binding capacity Both 
features of purified a^AT disappeared in the presence of MBP The tests with агМ 
revealed that the formation and stability of the complex between ajM and protease 
were reduced 
The results of this study suggest that MBP causes an increase in proteolytic activity 
by inactivating protease inhibitors The potential relevance of these results for demveli-
nating processes in man and animal is discussed 
Accepted for publication August 28, 1984 
Myelin basic protein (MBP) has been investigat­
ed thoroughly because of its encephalitogemcity 
following inoculation in genetically susceptible 
animals and its presumed role in the immuno-
pathology of multiple sclerosis (MS) Most re­
search has dealt with the immunological proper­
ties of MBP, both cellular and humoral, and 
revealed that the former is important in eliciting 
expenmental allergic encephalomyelitis (EAE), 
while the latter is not. According to Hashun &. 
Sharpe (1), the cellular immunogenicity of MBP 
is indeed important, but insufficient to account 
fully for its encephalitogemcity. Therefore, it 
seemed important to look for mechanisms of 
MBP complementary to its immunogenicity In­
creased proteolytic activity has been demonstra­
ted in the border zones of plaques (2, 3), in 
blood (4) and cerebrospinal fluid (CSF) (5) of 
patients with MS and in central nervous tissue of 
animals with EAE (6). This proteolytic activity 
Key words Alphai antitrypsin. аІрГіагтасгодІоЬиІіп iso­
electric focusing, myelin basic protein trypsin binding ca­
pacity 
may cause destruction of nervous tissue, or more 
indirectly, activation of other processes, includ­
ing the complement system (7). Therefore, pro* 
tease inhibitors might be important in the regula­
tion of inflammatory processes in EAE (8) and 
MS (9) In the present report, the action of MBP 
on 2 protease inhibitors, alphai antitrypsin 
(aiAT) and alpha^macroglobuhn (ajM) is de­
scribed. Abnormalities in a^M from serum of MS 
patients have recently been reported (10). 
Materials and methods 
Punfied human at AT, bustone (from calf thy­
mus, Type III) and trypsin (from bovine pan­
creas, Type III) were obtained from Sigma (St 
Louis), human albumin from Kabi (Stockholm) 
Bovine MBP, isolated according to Deibler et al 
(11), was a generous gift from Or. Ρ Delmotte, 
Melsbroek, Belgium Human ai M was punfied 
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by a single chromatographic step according to 
Hubbard et al (12) and finally concentrated by 
ultrafiltration to 2 mg/mi in tra buffer, pH 8.0 
Anti-human-a2M antiserum was obtained from 
the Central Laboratory of the Netherlands Red 
Cross Blood Transfusion Service, Amsterdam. 
at AT and a^ M were studied using 2 biochemical 
characteristics of these proteins, viz. their isoelec­
tric points and their tiypsin-binding activity, as 
described below. 
Alpha-iantitrypsin 
The pattern of a|AT was studied by isoelectric 
focusing (JEF). The Polyacrylamide gels were 
either prepared according to instructions of LKB 
(Bromma) or obtained from LKB directly The 
anntrypsin activity of punfied aiAT (2 mg/ml in 
saline), CSF and serum was measured according 
to Hoffman et al (13). This method is based upon 
the tryptic degradation of N-a-benzoyl-1-arginine-
p-nitroamlide (l-BAPNA), which is detected co-
lonmetncally The inhibition by a ι AT on the rate 
of this degradation is calculated. 
Alpha2macroglobulin 
аг M was studied by crossed Immunoelectrophore­
sis (CIE) according to Ohlsson & Skude (14). 
Using this method, any change in intensity of 
each protem band after ŒF can be measured 
semi-quantitatively. After ŒF on a gel with pH 
range of 3.5-9 5, a strip containing the protein 
bands was transferred to a 1% agarose gel con-
taining 2% anti-a2M antiserum. Then electropho-
resis was performed at right angles to the pre-
ceeding IEF. The activity of ajM was measured 
using its unique ability to bind trypsin without 
inhibiting the tryptic activity against l-BAPNA 
completely. Thus, it protects trypsin from com-
plete inhibition by a! AT (15). In short, trypsin 
(0.1 mg/ml in tns buffer, pH 7 8) was incubated 
with punfied a^ M or serum for 0.5 mm at 20° С 
and subsequently with ajAT (4 mg/ml in saline) 
to inhibit excess trypsin. Then the tryptic activity 
was measured as in the antitrypsin assay mention­
ed above. This activity reflects the amount of 
trypsin bound to агМ. Human CSF, concentrated 
up to 50-100 times, did not exhibit ajM activity. To 
measure the effect of MB Ρ on a, AT and a
:
M in 
these tests, the sera or solutions were incubated 
before testing with an equal volume of various 
concentrations of MBP As control, histone solu-
nons in the same concentrations as MBP were 
used. Besides, the effect of MBP on the intnnsic 
proteolytic activity of sera from different sour­
ces, human CSF and solutions of the protease 
inhibitors was measured as in the antitrypsin 
activity test, except that no trypsin was added. 
Statistics 
Statistical evaluation was earned out using the 
Wilcoxon test, with Ρ=0.05 as the upper limit of 
significance. 
Results 
a!AT pattern 
The IEF pattern of punfied aiAT is shown in 
Fig. la and consists of an anodic part of about 7 
bands, representing a, AT and a cathodic pan. 
consisting predominantly of albumin. The a, AT 
bands were absent from their normal location 
around pH 4 5 when MBP was added to purified 
ajAT in a dry weight ratio of 1 2 (Figs lb and 
c) Histone added in comparable amounts failed 
to show this effect. After the addition of ambu-
mm (3 mg/ml final concentration), the pattern, 
though appeanng weaker, did not disappear m 
the presence of MBP In serum, MBP did not 
influence the pattern of aiAT (results not 
shown). 
a,AT activity 
The results of the antitrypsin activity test with 
punfied ai AT are shown m Table 1. MBP inacti­
vated a ι AT completely when the dry weight 
ratio was again 1:2. Histone did not cause signi­
ficant mactivation Addition of albumin, how­
ever, diminished the mactivation of aiAT by 
MBP. In serum, aiAT was not inactivated by 
MBP (Table 1). In a separate set of experiments, 
we compared the antitrypsin activity of punfied 
a [AT with human serum and CSF, concentrated 
2.5-5 times. The results are shown in Fig 2 and 
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a. physiological saline 
b. MBP 1.0 mg/ml 
с MBP 0.1 mg/ml 
d. histone 1.0 mg/ml 
Fig. I. The effect of MBP and histone on the IEF pattern of purified ai AT. MBP and histone were dissolved in 
saline and incubated overnight with purified a ι AT (2 mg/ml). Final concentrations are shown. The anode was on 
the left. 
confirm the absence of any effect of MBP in 
human serum, but reveal a clear effect of MBP 
on the antitrypsin activity in CSF. 
a2M pattern 
The CIE pattern of purified a^M consisted of 2 
or 3 peaks (Fig. 3b). Addition of trypsin to a^M 
caused the most cathodic peak (fraction III) to 
increase, while the more anodic fractions (I and 
II) diminished (Fig. 3d). Such a rearrangement is 
termed here a cathodic shift of the pattern. The 
a^M pattern of serum and plasma showed one 
large and one small fraction, corresponding to 
fractions I and II of purified a^M. respectively. 
Upon addition of trypsin, fraction III appeared 
Table I 
The effect of MBP and histone on the antitrypsin activity of 
purified a ι AT and human serum 
Saline 
MBP 0.1 mg/ml 
MBP 1.0 mg/ml 
MBP 5.0 mg/ml 
Histone 1.0 mg/ml 
Histone 5.0 mg/ml 
Antitrypsin Activity (IU/1 ± SD) 
ai AT 
515±90 (η = 4) 
639+122 (л = 3) 
0 ± 0 (л = 6)· 
21 ±43 (я-6) · 
517±17 (л = 2) 
404+163 (л = 4) 
Serum 
1610+134 (n-3) 
1340 (л=1) 
1471 ±221 (л-2) 
1483 ±327 (л-3) 
1776 (л=1) 
1451 (л=1) 
Data represent mean inhibitor units per liter. 
(IU/1) out of л measurements. 
' Significantly different from the saline control 
Final concentrations are shown. Mixtures were incubated over­
night at 20° С 
and fraction I diminished (not shown). The effect 
of MBP on the pattern of purified a^M was 
opposite to that of trypsin: an anodic shift. In 
addition, MBP antagonized the cathodic shift 
caused by trypsin (Ftgs. 3a and c). In serum, this 
effect of MBP on the a^M pattern could also be 
found, albeit inconsistently. 
Percentaqe inhibition 
100 
0 1.0 2.0 3.0 4.0 5 0 MBP 11119/mlI 
Fig. 2. The effect of MBP on the trypsin inhibition by 
aiAT, serum and CSF. MBP was incubated for 1 min 
with ai AT (2 mg/ml), normal human serum or pooled 
human CSF. concentrated 2.5-5 times. 
202 R С VAN DER VEEN ET AL 
I II III I II 
b 
pH 
τ h 
Ч г 
6 pH 5 
Fig 3 The effect ot MBP and trypsin on the CIE pattern ot punhed d;Vl The j ; \ l solution (I mg ml) wj·, 
incubated for 15 sec with MBP (2 mg/ml) (a), water (b) MBP and trvpsin (45 ug/ml) (c) or trvpsm (d) Final 
concentrations are shown The anode of the first step (IEF) was on the left and ot the second step (electrophore 
sis) on top 
a2M activity 
A representative result of the ajM-activity test 
with punfíed ajM is shown in Table 2. The tryp-
sin-protectmg activity of punfíed a? M was dimi-
nished by more than 50% in the presence of 
MBP. In human serum, the activity of a2M was 
completely inactivated by MBP at 5 mg/ml, 
whereas histone caused practically no inactivation 
(see Table 2). 
Proteolytic activity 
The results shown in Fig 4 reveal no increased 
proteolysis in human serum, but a modest in-
crease caused by MBP in human CSF and m ai AT 
and a^ M solutions and a strong increase in vanous 
animal sera. The increase in proteolytic activity 
after the addition of MBP cannot be ascribed to 
copunfied proteases (16), since the intrinsic pro-
teolytic activity of the MBP solutions used was 
less than 0 5 milhextinction units 
Discussion 
a,AT 
In the present report, it is shown that MBP 
changed both the IEF pattern and the antitrypsin 
activity of aiAT. Testing the inactivation of 
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ai AT by MBP over a pH range of 6.0-7.8 show­
ed that it was pH-independent (unpublished 
data). These results suggest an interaction be­
tween the protease inhibitor and MBP, which 
seems rather specific because of the negative 
results obtained when MBP was replaced by 
histone in these tests. However, the experiments 
with albumin showed that other proteins, and 
perhaps lipoproteins, interfere with this interac­
tion. Possibly this was a reason for not detecting 
any effects of MBP on ai AT in serum. 
Crossed immuno-electrophoresis of a? M in se­
rum revealed 2 a^M fractions. According to 
Ohlsson & Skude (14), who found the same a?M 
pattern in serum, the first (anodic) fraction con­
sists of unbound a
:
M, while the second (catho-
dic) fraction contains protease-bound a
:
M. In 
the present study, it is shown that a third, still 
more cathodic, fraction exists. The existence of 3 
аг M fractions is in concordance with the 2 pro-
tease-binding sites on a
:
M. Thus, fractions II 
and III probably consist of a^M bound to one 
and 2 proteases, respectively (see Fig. 3). This 
hypothesis is strengthened by the almost comple­
te shift of the pattern to fraction III in the 
presence of excess trypsin. Addition of MBP to 
purified аг M diminished the 2 cathodic fractions 
or made them disappear. This suggests that 
either the bound proteases had been released, or 
MBP was bound to the a^M-protease complex 
Table 2 
The effect of MBP on the tiypsin-protecting activity of punned 
a2 M and human serum 
Rat serum 
protected activity (mE ± SD) 
аг M + saline 
агМ + МВР 
serum + saline 
serum + MBP 
serum -f histone 
Ι9±2(π«5) 
7 ± 2 ( η - 5 ) · 
9±5(η=-6) 
- І ± 3 ( я - 6 ) · 
11±3(η-3) 
Rabbit serum 
1.0 2.0 3.0 4.0 S.O MBP (mg/ml) 
Fig. 4. The effect of MBP on the intrinsic proteolytic 
activity ol sera. CSF and solutions of protease inhibi­
tors. 
Data represent mean milliexttnction units (mE) out of л mea­
surements. after inhibition of free trypsin by excess a ι AT. 
* Significantly different from the saline control. The final 
concentration of MBP and histone was S mg/ml. 
Demyelination 
Fig. 5. A hypothetical scheme of the mechanism by 
which MBP supports the inflammatory circuit leading 
to prolonged demyelination. -к stands for a stimulating 
and - for an inactivating mechanism. 
specifically. The former suggestion, viz. that pro­
teases bound to аз M are released by the action 
of MBP, is supported by the finding that some 
enzymatic activity appeared when MBP was ad­
ded to the a? M solution. This process also occur-
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red in solutions of ai AT as well as in animal sera 
and human CSF. The ajM-activity test showed 
that MBP inactivates the trypsin-binding capacity 
of ai M. The specificity of the reaction was 
shown by the absence of any effect of another 
basic protein, i.e. his tone, on the trypsin-binding 
capacity of a2M although histone is known to 
precipitate a^ M (17). Therefore, in addition to 
its dissociating effect on the complex of a^ M and 
complex formation. This was shown by both 
crossed immuno-electrophoresis and trypsin-bind­
ing capacity. 
From these results, it can be concluded that 
MBP probably inactivates protease inhibitors ra­
ther specifically in 2 ways. Firstly, it inhibits the 
formation of the complex between protease inhi­
bitors and protease. Secondly, it dissociates the 
complexes already present in solution. Thus, 
MBP causes an increase in proteolytic activity 
and duration. In agreement with this is the in­
crease in proteolytic activity found in MS (2-5) 
and EAE (6). Koetsier et al (18) showed that the 
activity of a, AT in CSF of MS patients is decreas­
ed, suggesting a higher degree of protease com-
plexing or inactìvation of ajAT. In view of the 
possible role of MBP in MS and EAE, it is 
suggested that the features of MBP presented 
here augment the inflammatory demyelinating 
processes in these disorders. However, it should 
be stressed that the concentrations of MBP used 
in this in vitro study are rather high and are not 
likely to be found in blood and CSF. Neverthe-
less, the in vitro processes described here are not 
thought to occur systemically but may occur local-
ly in central nervous tissue at a site of myelin 
breakdown. The failure to detect the inactivating 
effect of MBP on aiAT in human serum in this 
study does not contradict the hypothesis of a 
process occurring locally in the CNS, where the 
environment might differ from blood. Here, the 
inactìvation of protease inhibitors, caused by 
MBP, could have various consequences, some of 
which are shown in Fig. S and discussed below. 
Firstly, protease is able to activate leukocytes 
(19). In addition, a^ M suppresses various immune 
processes in vitro (19) and the suppression is 
caused by the ajM-protease complex predomi-
nantly (12). Therefore MBP, which is shown here 
to inhibit the formation of the агМ-ргоtease com­
plex, can be expected to stimulate immune pro­
cesses. Indeed, Sheffield & Kim (20) showed that 
MBP activates lymphocytes nonspecifically. Se­
condly, the increased proteolytic activity follow­
ing inactìvation of protease inhibitors by MBP 
may act on nervous tissue directly, and thirdly it 
may activate other injurious processes as well, 
notably the complement system. Recently, it has 
been shown that MBP added to serum causes 
activation of complement (21). The present 
study suggests that this may be induced by unin-
hibited proteases. The inflammatory processes 
discussed above could all lead to demyelination, 
thereby releasing more MBP (see Fig. 5). This in 
tum could again inactivate the protease inhibi-
tors locally that should normally be able (when 
active) to interrupt, at least partly, the circular 
and self-perpetuating process of inflammation. 
In conclusion, the inactìvation of protease inhibi-
tors by MBP could result in persistent and ex-
panding inflammation of nervous tissue, thus 
releasing fresh MBP continuously. It is proposed 
here that this process could play a role in MS 
and EAE locally, and that it might be stopped by 
masking MBP or by increasing the amount of 
protease inhibition. 
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Summary: Suramin was tested for its ability to suppress experimental 
allergic encephalomyelitis. Prophylactic administration caused 
significant reduction in the severity of the disease, incidence of 
paralysis and cellular infiltration In nervous tissue. Therapeutic 
treatment with suramin also caused a reduction in the severity of the 
disease, the Incidence of paralysis and cellular infiltration, but to 
a lesser extent. Significantly fewer animals were paralysed for more 
than two days on therapeutic treatment. 
Experimental allergic encephalomyelitis (EAE) is an autoimmune inflammatory 
disease of the central nervous system (CNS) Induced in animals by immunization with homo-
genate of spinal cord, white matter of the brain or myelin basic protein (Brosnan, С animer, 
Norton and Bloom, 1980; Kies, 1973; Paterson, 1976). Both cellular (Paterson, 1976; Holda, 
Welch and Swanborg, 1980; Gonatas and Howard, 1974; Ortiz-Ortiz and Welgle, 1976) and 
humoural (Horarlu and Dalmaaso, 1978; Kuwert, 1963; Appel and Bornsteln, 1964) reactions have 
been implicated in the pathogenesis but it is not known which of the two mechanisms initiates 
the disease. 
Recently, it has been shown in this laboratory that suramin suppresses complement 
fixation, cullular infiltration and destruction of vessel walls during the Arthus reaction 
In experimental animals (Asghar, Kammeijer, Dingemans, Faber, Siddiqui and Cornane, 1983; 
Asghar, 1984). This communication describes the results of a preliminary study which showed 
that administration of suramin caused a significant reduction in the clinical and pathological 
expreasion of experimental allergic encephalomyelitis in Lewis rats. 
METHODS 
Immunization of rats; Male inbred Lewis rata, weighing lS0-200g, were injected intraderaally 
on day 0 with 0.1 ml of an emulsion containing equal volumes of guinea pig spinal cord, 
homogenized in phosphate-buffered saline (200 mg/ml) and complete Freund's adjuvant, 
containing 10 mg/ml Myaobaateriiun tubercolosis, killed with heat. 
Prophylactic and therapeutic treatment with suramin: In experiments designed to study a 
prophylactic effect a group of eight rats was injected intravenously daily with 0.1 ml (3 ag) 
of suramin (Bayer Pharmaceuticals, Leverkussen, W. Germany), starting on day -1. Ten sensit­
ized rats, which were not given suramin, served as controls. In experiments aimed at studying 
therapeutic effects, 10 mg of suramin dissolved in 0.1 ml of distilled water, was administered 
intravenously to 8 rats on day 10 and 9 mg on days 11 to 16. Nineteen sensitized control rats 
were injected with 0.1 ml of distilled water instead of suramin. 
Clinical assessment: The rats were weighed daily and scored for clinical expression of 
experimental allergic encephalomyelitis according to the method of Mertln and Stackpoole 
(1978), except that the scale was extended to nine points, ie.: 0 » no symptoms: 1 = tail 
flaccidity; 2 » 1 • ataxia or 1 + Incontinence; 3 =• 1 -• ataxia + incontinence; 4 » paresis 
of the hind legs; 5 = 4 * incontinence; 6 » paralysis of the hind legs; 7 » 6 • incontinence; 
8 - paralysis of hind and front legs; 9 » death. 
* Present address: Shriver Center, 200 Trapelo Road, Waltham, Bolton, Massachusetts, USA. 
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Histology: For histological studies, a piece of 4 m of the lumbar part of the spinal cord 
was dissected soon after death and frozen. From this material, a longitudinal section, S va 
thick, was prepared on a cryostat and stained with Sudan Black and haematozylin. Bach 
infiltrate was scored In a standardized area (0.006 um2)(l я lesa than SO; 2 • 90 to 99; and 
3 » 100 to 149 cell· and so on) and the extent of infiltration per am2 of central nervous 
tissue for each section was calculated. 
Statistical evaluation of the resulta; For statistical evaluation, a distribution-free test 
(koalol, Maxwell, Fukuahlma, Colmeranea and Pitch, 1981)("overall test"), appropriate for 
the detection of ordered alternative of distribution, was applied to each group for daya 10 
to 17. If the differences were significant (p < O.09), a Wllcoxon test was performed for each 
days to evaluate the differences between the two groupa more precisely. Comparison of the 
Incidence of experimental allergic encephalomyelitis or paralysis, and the duration of 
paralysis, was made with the exact Fischer test (one-sided). The histological results were 
analysed with the Wllcoxon test (significant if ρ < 0.09). 
RKSULTS 
Iffect of prophylactic administration on the development of experimental allergic 
encephalomyelitis: Figure 1 shows the effect of prophylactic treatment with suramin on the 
development of experimental allergic encephalomyelitis. The dally median clinical score· of 
rata treated with suramin, and of the control groupa, are shown in Figure la. The reduction 
in the severity of the disease in the group treated with suramin was statistically significant 
with the "overall test". The daily Wllcoxon teats showed a significant reduction on daya 10 
to 19. The loss of weight in the group treated with suramin was not different from the control 
group. The difference in the incidence of paralysis (score β or more), which reached 
statistical significance on days 11 (p < 0.02), 12 (p < 0.004) and 13 (p < 0.03), is shown in 
Figure lb. The incidence of experimental allergic encephalomyelitis (score 1 or more) was 
reduced, but not appreciably, In the group treated with suramin (Fig. 1c). The mortality In 
the control group waa greater, four In the control group compared to none in the group 
treated with suramin (Fig. la) but the difference waa not significant (Fisher test). The 
median extent of infiltration In the CMS in the group treated with suramin was Ο.β (range 
0.3 to 0.8) and In the control group 2.0 (range 0.9 to 3.0). The reduction was statistically 
significant. 
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Figure 1. Effect of prophylactic regimen of suramin on the development of experimental 
allergic encephalomyelitis in sensitized rats. Experimental conditions are described 
In the text. 0-0 control group; ·-· suramln-treated group; + death of one animal. 
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Effect of therapeutic admlnlatratlon of suramin on experimental allergic encephalomyelltla: 
Figure 3 show· the effect of therapeutic treatment with suramin on the development of 
experimental allergic encephalomyelltla. The reduction In aeverlty In the group treated with 
suramin (Fig. За) was not statistically significant in the "overall teat". The incidence of 
paralyais perday in the treated group waa leaa than in the control group (Fig. 3b) but did 
not reach significance on any single day. However, when the duration of paralysis waa 
compared, there were significantly fewer animals paralyzed for more than two days in the 
group treated with suramin (p < 0.03). The incidence of experimental allergic encephalo­
myelltla in both groupa waa not significantly different. The median extent of infiltration 
waa 0.8 (0.3 to 3.9) for the group treated with auraaln and l.B (Ο.β to 3.7) for the control 
group. This difference waa atatiatlcally significant. 
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Figure 3. Effect of therapeutic regimen of suramin on the development of experimental 
allergic encephalomyelltla In sensitized rata. Experimental conditloaa are 
described in the text. 0-0 control group; ·-# auramln-treated group; + death 
of one animal. 
DISCUSSION 
The results obtained in thia atudy show that experimental allergic encephalo­
myelitis waa auppreaaed by a prophylacti regimen of suramin. The severity of the disease, 
cellular Infiltration and the incidence of paralyais were significantly reduced. The thera­
peutic regimen showed comparatively low efficacy. Theae reaulta suggest that suramin may 
Inhibit one or more of the initiating processes leading to clinical experimental allergic 
encephalomyelitis. 
The effects of suramin on cellular and humoural immune reactions have not been 
thoroughly atudled. It la known to be a atrong inhibitor of complement (Fong and Good, 1973; 
Conrow, Bauman, Broekman and Bernstein, 1980). It has been shown to suppress complement 
fixation , cellular infiltration and destruction of vessel walls during the Arthua 
reaction in rabbits aa did aome other complement Inhibitors (Aaghar et al., 1983; Aaghar, 
1984. Suramin also appeara to inhibit certain lysosomal enzymes and their releaae. Ackerman, 
Jubb, Trimble, Marlowe, Miram and lialoney (1983)have shown the inhibition of the release of 
enzymes splitting cartilage proteoglycan from mouse macrophage, by suramin. S-Glucoroaidaae 
and cathepain D of macrophages of mouse and rat were also inhibited. Suramin suppressed the 
autolytic releaae of proteoglycan from cultured rabbit knee, indicating inhibitory activity 
againat a chondrocyte-derlved neutral protease. It waa, however, ineffective in preventing 
degradation of cartilage during adjuvant arthrltia. 
In view of the limited knowledge of the effects of suramin on cellular and 
humoural Immune reactions, it is not possible to postulate the mechaniam for the suppression 
of experimental allergic encephalomyelitis by this drug. However, since complement appears 
to play a role in experimental allergic encephalomyelltla (Kuwert, 1963; Morariu and 
Dalmaaao, 1978), it would be interesting to find out whether the suppressive effect of 
suramin on experimental allgeric encephalomyelltla la due to Ita complement-inhibiting 
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property. A clear-cut demonstration is a difficult task. The lowering of levels of 
complement in blood by administration of suramin has already been shown (Conrow et al., 
1980) in guinea pigs but this does not prove that complement inhibition is the casue of 
suppression of experimental allergic encephalomyelitis since, in spite of the decrease in 
complement levels, the drug may be working through other mechanisms. One of the approaches 
being followed is to examine the effect of many complement inhibitors of diverse structure, 
and which have in common only the complement-inhibiting property, on experimental allergic 
encephalomyelitis. 
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CHAPTER VII 
DENSITOMETRIC ANALYSIS OF MYELIN DISRUPTION AFTER INCUBATION 
WITH SERUM AND MYELIN BASIC PROTEIN 
R.C. van der Veen 
(submitted) 
abstract: Journal of Neurochemistry 46: S136. 19Θ7. 
ABSTRACT 
The early events during myelin disruption in demyelinating disorders 
remain to be elucidated. The present study describes attempts to develop a 
procedure for the measurement of myelin density and its use in the analysis 
of myelin disruption. After incubation of fresh myelin suspensions, 
followed by ultracentrifugation on a continuous sucrose gradient, the 
density distribution of myelin was analyzed turbidometrically. Incubation 
in the presence of normal autologous serum resulted in an increased myelin 
density, which was associated with myelin disruption as indicated by 
electron microscopic analysis. 
This procedure was used to study the effect of free myelin basic 
protein (MBP) on the course of myelin disruption by normal autologous 
serum. Exogenous MBP, previously shown to increase serum proteolytic 
activity by binding protease inhibitors, significantly enhances serum-
induced myelin disruption. The effect of MBP is specific since it cannot 
be replaced by histone. Furthermore, the addition of MBP antiserum 
overcomes the effect. In addition to proteases, serum complement is at 
least partly operative in this form of myelin disruption as shown by the 
effect of heat inactivation. These results suggest that endogenous MBP may 
participate in the continuation of myelin disruption after its release from 
the myelin membrane. 
INTRODUCTION 
Experimental allergic encephalomyelitis (EAE) is a valuable model for 
the study of autoimmune and genetic aspects of multiple sclerosis (MS) 
(Alvord, Kies and Suckling 1984, Raine 1984), and can be elicited by the 
major myelin proteins myelin basic protein (MBP) and proteolipid protein 
(PLP). While the cellular and humoral immune cascades may account for the 
specific phenomena in EAE, the mechanisms of non-specific myelin 
degradation, that precede phagocytosis, are unclear. Nevertheless, non-
specific demyelination, without direct involvement of immunologically 
specific myelin recognition, seems to play an important role in 
demyelinating processes (Visniewski and Bloom 1975), and may be involved in 
the continuing demyelination, that is observed in chronic EAE and in MS 
(Prineas et al 1984). As previously reviewed (van der Veen et al 1985a), 
proteases such as plasmin may be involved in these processes, either by the 
direct proteolysis of myelin or by the activation of complement. Recently, 
Alvord et al (1985) reported the development of a new form of chronic EAE, 
in which demyelination occurs mainly in the absence of infiltrating 
leucocytes. They suggested this to be of proteolytic origin, thus 
stressing the potential importance of proteolysis in demyelination. 
In addition, serum protease inhibitors are known to control 
inflammatory reactions (Revillard et al 1984), and their inactivation in 
the presence of exogenous MBP results in an increased tryptic-like activity 
in serum and CSF (van der Veen et al 1985a). 
To study the role of these processes during myelin disruption, myelin 
density was measured in order to monitor its integrity after incubation 
with autologous serum with or without exogenously added MBP. The density 
changes were analyzed on continuous sucrose gradients, and were shown to be 
associated with ultrastructural changes. Changes in myelin density have 
previously been observed following disrupting conditions (Konat and Offner 
1982a, 1982b, Reigner et al 1981). 
METHODS 
A. Preparation of components. 
Adult New Zealand White rabbits (ARI, Avon, MA) and strain 13 guinea 
pigs from our own breeding colony were used. For each experimental series, 
a single animal was anaesthesized with ketamin (Vetalar, Park Davis, Morris 
Plains, NJ) and sacrificed by cardiac exsanguination. After clotting of 
the blood, serum was collected and stored at 40C. Crude myelin was 
purified from the same animal by a modification of the method of Norton and 
Poduslo (1973). White matter-enriched brain tissue was homogenized in 
0.32M sucrose, overlaid on 0.85M sucrose and centrifuged at 70,000x g for 
45 minutes in a Beekman L2-65B ultracentrifuge. The interface material was 
collected, washed and resuspended in water at a protein concentration of 
10mg/ml, which was measured by the Lowry procedure as modified by Lees and 
Paxman (1972). The suspension was stored at 40C and used within three 
days. Further purification of this crude myelin preparation, that 
contained vesicles with enclosed axonal material (Sarma and Sitaraman 
1982), was not pursued in order to keep the myelin structurally intact. 
Instead, analytical centrifugation on continuous sucrose gradients enriched 
the myelin fraction by separating it from free axonal material that was 
released from the myelin vesicles during the incubation. 
B. Incubation. 
Aliquots of myelin suspensions were incubated in the presence of 20% 
(v/v) normal autologous serum in micro test tubes at 370C for 1 hour. The 
incubation was terminated by placing the tubes in an ice-water bath. The 
incubated myelin was either analyzed directly or stored at -20eC, which 
had no effect on subsequent density measurements. 
C. Density analysis. 
Myelin samples (0.2 ml) were diluted in 3ml sucrose (5% w/v), and 
layered on top of a continuous sucrose gradient (10% w/v to 30% w/v, 
prepared using a Hoeffer, type HSI gradient mixer). After centrifugation 
at 110,000x g for 90 min. at 40C, the gradient was placed on a 
fractionator (ISCO, Lincoln, NE) and pumped at room temperature through a 
flow cell of a Hewlett Packard 8451A diode array spectrophotometer, 
programmed to measure the optical density (O.D.) at 400nm every 0.1 sec. 
Subsequently, appropriate samples were fixed routinely for electron 
microscopy (EM) or stored at -20eC for SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) according to Laemmli (1970). To correct for the 
biological variability in the effect of different sera, the controls for 
the experimental conditions were tested simultaneously and presented in the 
same figure. The density in the figures is expressed as molarity of 
sucrose (M). 
D. Antisera and other reagents. 
Antiserum to MBP was obtained by first immunizing rabbits 
intradermally with O.lmg rabbit MBP (Calbiochem, La Jolla, CA) emulsified 
in incomplete Freund's adjuvant (IFA), followed by injections of 1.0 and 
0.5 mg MBP in complete adjuvant (CFA) at 3 weeks intervals. When ELISA 
tests indicated a sufficiently high antibody titer, serum was collected by 
cardiac exsanguination. Antiserum against total CNS tissue was obtained by 
immunizing guinea pigs intradermally with 0.2 ml of a 50% guinea pig spinal 
cord suspension in water emulsified in an equal volume of IFA, followed by 
a similar immunization in CFA 10 days later. The presence of anti-myelin 
antibodies was determined by a dot immunobinding assay (Lebar and Lees 
1985). Antiserum to galactocerebroside was a generous gift from Dr. C.S. 
Raine. Trans-4-(aminomethyl)-cyclohexanecarboxylic acid (AMCA), plasmin 
and histone were purchased from Sigma, St. Louis, MO. 
E. Statistical analyses. 
The quantity of myelin at high density was calculated by measuring the 
area under the turbidity curves (mm2) and enumerating the proportion of the 
myelin that banded at a density greater than 0.70 M sucrose. Analysis of 
variance was performed on the absolute data (Dixon and Brown 1985). 
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Figure 1. 
Density distribution of myelin from rabbit brain after incubation with serum and 
MBP myelin incubated with PBS. myelin incubated with serum {20% 
v/v final concentration) the arrow indicates the shoulder at high density. 
myelin incubated with serum and MBP (0.8 mg/ml final concentration). 
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RESULTS 
After centrifugation on the continuous sucrose gradients, fresh myelin 
showed a bell-shaped density distribution with a mean peak, value at 
0.65+0.02 M sucrose (n=8), corresponding to 1.085 g/ml. The distribution 
of turbidity in the gradient coincided with the distribution of the major 
myelin proteins, as determined by SDS-PAGE analysis of the gradient 
fractions. Incubation of rabbit or guinea pig myelin with normal 
autologous serum resulted in a shift of the turbidity curve towards higher 
density. After incubation with serum for 1 hour, the curve showed a 
shoulder at high density (arrow in Figure 1). With longer incubation (2 
hours or more), the peak of the curve shifted, indicating an increase in 
the median density of the myelin particles (data not shown). Structurally, 
the low density fractions (0.55-0.75M) contained many relatively intact 
myelin loops enveloping axonal material (Figure 2). By contrast, smaller 
myelin fragments were observed in the high density fractions (greater than 
0.75 M sucrose), where much of the laminar organization was lost. However, 
some multilamellar structures, typical for normal density myelin, were 
still present. The protein composition of high density myelin, as 
determined by SDS-PAGE, was similar to the normal density myelin. 
The ultrastructure of rabbit brain myelin after incubation with normal serum ana 
subsequent fractionation on a density gradient. A. Density 0.55-0.75 Μ В. 
density > 0.75 M sucrose. Bar = 1 μη 
The involvement of proteolytic activity in the serum induced density 
shift is suggested by the enhancing effect of additional plasmin (Figure 
3). Because free MBP enhances proteolytic activity, its effect on the 
myelin density shift was studied. The addition of MBP to normal serum 
before incubation with myelin resulted in a shift in the position of the 
turbidity peak to approximately the same position, where the turbidity 
curve formed a shoulder after incubation with serum alone (Figure 1). The 
extent of the density shift correlated with the MBP concentration (Figure 
A) and the incubation time. Incubation of myelin with MBP in buffer (in 
the absence of serum), did not cause a shift in the position of the density 
peak (not shown). To enable the quantification of the density shift, the 
results of a series of similar experiments using different myelin and serum 
preparations have been combined in Table 1, and are expressed as the 
proportion of the high density fraction of the myelin suspensions. These 
results demonstrate that, although the density distribution of the myelin 
suspensions varied somewhat from one experiment to another, in every 
instance the serum induced increase in density was enhanced by the addition 
of MBP to the serum. The difference between the high density fractions 
with or without the addition of MBP, was significant (p=0.005). 
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Figure 3. 
Effects of plasmin on myelin density. myelin incubated with serum. 
myelin incubated with serum and plasmin (40 ng/ml final concentration). 
Arrow indicates the shoulder at high density caused by plasmin. 
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Figure 4. 
Density distribution of rabbit brain myelin after incubation with different MBP 
concentrations. myelin + serum, o-o-o-o myelin + serum + MBP (1 mg/ml 
final). myelin + serum + MBP (2 mg/ml final). 
Table 1. The relative proportion (%) of myelin fractions with 
high density after incubation under different conditions. 
mean + S.D. 
Myelin 2.6 20.8 12.4 11.9+9.1 
Myelin + serum 21.6 30.0 49.1 48.1 34.4 36.6+11.9 
Myelin + serum + MBP 29.7 63.4 53.8 56.8 53.8 53.7+14.2 
The data represent the percentage of the total area under the turbidity curv 
with a density greater than 0.70 M sucrose, and were calculated for five 
separate experiments as described in Methods (section E). 
1,2,3: Incubated myelin and serum from rabbits, 4,5: from guinea pigs. 
: Not tested. 
A) В) 
Figure 5. 
The ultrastructure of rabbit brain myelin after incubation with PBS (A), or 
serum with MBP (B) or without MBP (C). Bar ш 0.1 до 
Structurally, myelin incubated with both serum and MBP showed a high 
degree of disruption, with many small and vesiculated fragments and little 
multilamellar organization (Figure 5). After incubation with only serum, 
the myelin structure showed an intermediate degree of organization between 
myelin incubated with buffer and with both serum and MBP. High power EM 
studies however revealed that the high density myelin still contained some 
multilamellar fragments with an apparently normal periodicity. After SDS-
PAGE of the myelin samples, densitometric scanning of the gels showed no 
major differences in the pattern of myelin proteins after incubation for 
one hour with or without serum and MBP. Only after incubation for several 
hours, a loss in myelin proteins became obvious. 
The specificity of the effect of MBP on myelin density was tested in 
two ways. First, the addition of similar quantities of histone to normal 
serum before incubation with myelin did not alter the density. Second, the 
addition of MBP antiserum prevented the density shift caused by exogenous 
MBP (not shown). 
Inactivation of serum complement (60 minutes at 56eC) or the addition 
of the protease inhibitor AMCA resulted in a partial inhibition of the 
density increase caused by MBP (Figure 6). The addition of AMCA caused a 
reduction in the turbidity peak around 0.70 M sucrose and an increase 
around 0.60 M sucrose, resulting in a curve with a dual peak. 
0. D. a 6 
0.4 
0.2 
0.0 
0.80 0.70 0.60 0.50 
Density (M sucrose) 
Figure 6. 
The effect of serum components on the density shift of rabbit myelin. 
myelin + serum + MBP (1 mg/ml final). .-.-.-.- AMCA (0.5 mg/ml final) added to 
serum, o-o-o-o heat inactivated serum (560C, 60 min). 
DISCUSSION 
A. Density redistribution. 
Centrifugation on a continuous sucrose gradient showed a density 
distribution of normal rabbit or guinea pig brain myelin centering around 
0.65 M sucrose (1.085 g/ml), as has been reported previously (Norton and 
Cammer, 1984). In the present study we report the increased turbidity of 
myelin at high density following incubation with autologous serum and the 
amplification of this effect after the addition of exogenous MBP. The 
increase in turbidity at higher density is interpreted as a shift in myelin 
density, because it is often coupled to a decreased turbidity at normal 
density. Secondly, the high density material has been identified mainly as 
myelin by electron microscopy and gel electrophoresis. The frequent 
appearance of a second peak after incubation indicates that the extent of 
the density increase is not random, but rather concentrates around a value 
between 0.70 and 0.80 M sucrose. 
Incubation of myelin with serum has previously been shown to result in 
an increased myelin density, which was independent of the nonspecific 
binding of serum proteins to myelin (Konat and Offner 1982b). In addition, 
increased myelin density on discontinuous sucrose gradients has been 
reported in myelin isolated from MS patients compared to healthy subjects 
(Konat and Offner 1982a), as well as from animals undergoing experimental 
demyelination (Reigner et al 1981, Konat et al 1982). Continuous gradients 
provide a better overview of the density changes and harbour the potential 
for monitoring subtle and thus early differences in myelin integrity 
(Figure 3). Using this method, spinal cord myelin revealed a lower density 
than brain myelin (van der Veen, unpublished), which could be explained by 
differences in protein content (Lees and Paxman 1974, Smith and Sedgewick 
1975). 
B. Relation of density increase to disruption. 
The exact nature of the density changes is not completely clear. 
Theoretically, an increase in myelin density may reflect several processes, 
including an increased water content, as a result of swelling or splitting 
of myelin lamellae, or a decreased lipid to protein ratio (Konat et al 
1982). The SDS-PAGE results suggest that the density increase and limited 
fragmentation observed in the present study do not coincide with a major 
protein loss. The presence of exogenous MBP however obscures the loss of 
endogenous MBP, the most vulnerable of the major myelin proteins. PLP on 
the other hand is shown by SDS-PAGE not to be degraded or removed from 
myelin at a measurable rate during the density shift. 
Theoretically, protein loss in itself would result in a decreased 
myelin density and thus counteract the density increase caused by serum and 
MBP. However, a major protein loss conceivably accompanies or follows such 
processes as the loss of myelin quantities by phagocytosis or the formation 
of lipid vesicles, and thus seems to be a parameter for more advanced 
disruption of myelin. The density increase presented in this study 
possibly represents a more subtle parameter and occurs during earlier 
stages of myelin disruption. Complement activity for instance could 
conceivably result in primary structural changes, with only minor changes 
in the myelin protein content. 
Using electron microscopy, we have shown that an increase in myelin 
density coincides with a disrupted structure, i.e. thinner fragments and a 
more vesiculated material. Similar differences in structure between heavy 
and light myelin have been reported previously (Matthieu et al 1973). In 
addition, the presence of complete myelinated axons in the myelin 
preparations permitted the structural study of myelin organization which 
was diminished in myelin with an increased density. Results from the 
incubation with CNS or galactocerebroside antisera, known to disrupt myelin 
(Fry et al 1974), confirmed the association of the density increase with 
disruption. The association however does not clarify whether the 
disruption caused the density increase, or vice versa. 
С Effect of MBP. 
In the current study we have shown that the addition of MBP to serum 
enhances the disruption of myelin by normal serum. The specificity of this 
effect appeared from its inhibition by MBP antiserum and from the lack of 
disruption by histone, previously shown not to inactivate protease 
inhibitors in contrast to MBP (van der Veen et al 1985a). The effect of 
MBP alone on myelin density was an important control in light of reports on 
endogenous or copurified proteolytic activity in MBP preparations (Deibler 
et al 1984). The lack of disruption by MBP in the absence of serum 
indicates the importance of the interaction, direct or indirect, between 
MBP and serum components. At least some of the components were identified 
as serum complement and proteases, which had been reported previously to be 
myelin disrupting serum components (Appel and Bornstein 1964, Cammer et al 
1978, Inuzuka et al 1984, Cammer et al 1986). 
In conclusion, this study shows that the turbidometric measurements of 
density changes provide a useful tool for monitoring myelin disruption. 
Using this method we have shown that free MBP enhances the disruption of 
myelin in the presence of serum, which provides a basis for future studies 
aimed at the inhibition of progressive demyelination. 
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CHAPTER Vili 
GENERAL DISCUSSION 
Chapter VIII. GENERAL DISCUSSION 
In this final chapter, the results fron the preceding chapters are 
discussed in relation to their background, as well as to each other. In 
the last part of the discussion, the conclusions fron this report are 
combined into an hypothetical sequence of the process of myelin 
disruption. Including possible directions for testing these hypotheses. 
A) CHARACTERIZATION OF Τ CELLS IN CNS INFILTRATIONS. 
Although the Issue of the differential CNS-infiltration patterns among the 
lymphocyte subpopulations is less controversial in EAE compared to MS, a 
better understanding of the kinetics of this process in EAE is essential 
to MS research, where one is very restricted in performing this type of 
studies. 
The reported continuing decrease in the W3/13-binding pan-T marker during 
the process of CNS infiltration indicates the continuing lymphocyte 
differentiation inside the CNS. In addition, it seems to justify the 
order in which the infiltrated brain compartments are arranged in 
relation to the sequence of lymphocyte infiltration (i.e. meningeal; 
compact, non-demyelinating perivenous cuffs; and diffuse, demyelinating 
parenchymal Infiltrations respectively; see also Lassmann et al. 1986, 
who basically used the зале subdivision in studying CNS infiltrations). 
Possibly of more direct importance Is the apparent accumulation of 
suppressor/cytotoxlc Τ cells In the meninges during the course of acute 
EAE, indicating that these cells Indeed accumulate in the CNS to some 
degree, but display a spatial restriction in doing so. Furthermore, the 
location of the accumulation of 0X-8+ lymphocytes renders both the 
cytotoxic and the suppressor cells among the ÒX-8+ lymphocyte population 
improbable candidates for a direct role in respectively the Induction or 
the regression of the demyelinating processes. This conclusion appears to 
disagree with other reports, suggesting a role in the clinical recovery 
for 0X-8+ cells, present In parenchymal infiltrations (Lassman et al. 
1986). On the other hand, the results do not rule out the possibility of 
a more distant, regulatory role for the meningeal 0X-8+ cells during 
clinical recovery. 
B) PLP-INDUCED EAE. 
The studies concerning differential CNS infiltration stress the importance 
of helper Τ cells In the*local induction of histological disease. In 
addition to the recruitment of macrophages, which results In the 
disruption and phagocytosis of myelin, one of the possible roles of these 
helper Τ cells In demyelination is providing "help" for В cells in the 
production of myelin-specific antibodies. 
In view of the fact that the level of MBP antibodies shows a lack of 
correlation with the disease activity, we studied the humoral response to 
another, less established encephalitogenic myelin protein, namely PLP. 
Before analysing the antibody levels, the Immunohistopathology and 
clinical pattern of PLP-induced EAE were studied first, and showed the 
characteristics of a cellularly mediated disease, including the 
accumulation of Τ cells and macrophages, but not of В cells, as well as a 
high degree of la expression. In addition, the DTH skin response, which 
Is generally mediated by helper Τ cells, correlated with the clinical 
activity. Meanwhile, the encephal1 togen 1 city of PLP has been studied by 
others In rats (Yamamura et al. 19Θ6) and mice (Trotter et al. 1987), 
while the cellular basis of this disease has been established firmly 
through transfer experiments (Satoh et al. 19Θ7). 
As shown before (Cambi et al. 19 Э), the PLP model revealed a closer 
resemblance to MS, In view of the chronic disease course following a 
delay in clinical onset, as well as the widespread demyelination, 
features that are conspicuously absent In the MBP-induced disease. 
These results drew our attention towards PLP antibodies as possible 
mediators of the extensive demyelination in PLP-induced EAE. Indeed we 
were able to show a correlation between circulating antibody levels and 
the clinical course in rabbits. This correlation was confirmed by others 
In guinea pigs (Endoh et al. 19Θ6). However, demyelination by PLP 
antibodies has not been observed directly (Mithen et al. 1980). 
An Interesting, although very preliminary observation was made in trying 
to locate the amino acid sequences in PLP, which are responsible for its 
encepha11 togen 1 с 1ty. 
Our first approach was to search for peptide sequences resembling the 
encephalitogenic MBP sequence for rabbits (realizing that this Is not 
necessarilly a requirement for the expression of encephalItogenic 
activity) : 
X-X-Tyr-X-X-X-X-Gln-Arg (Hashim and Sharpe 1974), 
where X stands for an Irrelevant spacer amino acid. Several PLP peptides 
were selected on this ground (or with Trp Instead of Tyr, which happens 
to be active In guinea pigs), among which was one peptide with the exact 
sequence as shown above, however In a reversed, mirrored direction, 
namely amino acids 97-105 : 
Arg-Gln-X-X-X-X-Tyr-X-X (Lees et al. 1984). 
In view of the recent developments linking the la binding of short 
peptides to their iramunogenlclty (Allen et al. 1987), It Is not 
Irrational to propose that a peptide could cross-react inmunolog!cally 
with Its mirror image. 
Therefore we performed preliminary experiments with a synthetic peptide 
homologous to the amino acid sequence 97-105 of PLP. The results showed 
that one out of two Inmunized rabbits developed weight loss and obvious 
CNS Inflammation, while both developed a positive DTH response after skin 
testing to the peptide itself as well as to whole PLP. In addition, 
PLP-inmunized rabbits developed a small but positive skin response to 
FIGURE 1. A hypothetical scheme of the mechanism by which 
MBP supports the inflammatory circuit leading to 
prolonged demyelination. 
+ stands for a stimulating and - for an inactivating 
mechanism. 
a. The role of proteases in 
inflammatory demyelination 
*-Otmytlin»tioft 
b. Modulation of inflammatory 
demyelination by protease 
inhibitors 
•-Denyelination 
c. Inactivation of protease 
inhibitors by MBP released 
during demyelination 
resulting in a positive 
feedback on demyelination Oemytllnation 
peptide 97-105. 
These results indicate that this sequence probably represents a major 
immunogenic peptide of PLP in rabbits, since four other selected 
synthetic PLP peptides did not give any of the above described results 
(although they covered only a part of the complete PLP sequence); in 
addition, peptide 97-105 seems to express encephalitogenic activity. 
Although cellular cross-reactivity between unfragmented PLP and MBP has 
not yet been observed, it would be Interesting to test whether the 
involved peptides from both proteins show cellular cross-reactivity in 
rabbits, even though their immunogenic sequences are reversed. 
C) NONSPECIFIC PROCESSES RELATED TO DEHYELINATION. 
The mechanisms described thusfar in the discussion relate to the 
inmune-specific processes. As discussed in the Introduction, nonspecific 
processes are thought to play an Important role as well, either by 
supplementing the immune-specific processes, or by acting independently. 
The results with the complement Inhibitor suramin Indicate a role for 
complement In the development of EAE, even, although with less 
efficiency, when actnlnlstered therapeutically, i.e. after the onset of 
clinical signs, when the Inflamnatory response In the CNS is well 
established. This indicates that suramin could be active at the site of 
neurological damage, suggesting the involvement of complement In myelin 
disruption. However, it does not exclude other possible levels of 
complement action, for instance during CNS infiltration. 
The activation of complement, besides Its Induclblllty by the 
inmune-specif1c binding of antibodies to myelin, could also result from 
the proteolytic activity, which is Induced by activated macrophages. 
Proteases are thought to play an important role during the effector phase 
of demyelinatlon. 
In general, proteases have been Involved in the enhancement of several 
Immune processes (Bever and Whltaker 19Θ5, Такayama et al. 19Θ7), while 
protease inhibitors induce immunological suppression (James 1980). Other 
reports have linked protease Inhibitors to HS (Koetsier et al. 1981, 
Rastogl and Clausen 1985, McCombe et al. 1985). 
The results described in chapter VI, showing the Inactivation of protease 
inhibitors by free MBP in vitro, Indicate that this effect of MBP might 
be operative in vivo. Thus, the early release of MBP during myelin 
disruption (Glynn et al. 1987) possibly triggers an increase in 
proteolytic activity, resulting in: sustained myelIn breakdown (thereby 
providing a continuous supply of free MBP), complement activation (which 
could be related to the inherent capability of myelin to activate 
complement) and reactivation of the local immune response (see Figure 1). 
Similar processes could also be involved in some dysmyelinating 
disorders, where myelin is degraded at a high degree (Matthieu and Oral in 
1984). 
FigureZ. Possible sequences of events leading to demyelination. 
The shaded area represents immunologically specific processes, while 
the rest comprises the aspecific part of the immune response. 
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The preliminary results from chapter VII indicate that free MBP, when 
added exogenous1 y to normal serum, indeed increases the disrupting 
effects of the serum on isolated myelin, probably through proteolytic 
mechanisms. 
One of the parameters used for myelin disruption in these studies was the 
bouyant density of myelin, analyzed by centri fugation on continuous 
sucrose gradients. In contrast to biochemical analyses, myelin density 
offers a potential parameter for the early changes in the myelin 
structure, like swelling. The morphological changes, that accompany the 
increased density, resemble the vesicular disruption of myelin, as 
observed early in the course of EAE, preceding phagocytosis (Dal Canto et 
al. 1975). Indeed, these authors stressed the role of early humoral 
disruption of myelin during demyelInatlon. 
After the further characterization of the processes Involved in the 
density changes, p.e. alterations in the lipid composition, the system 
used to study myelin disruption can be expanded to Include cellular 
immune phenomena, either myelin-specific or not, as discussed In the last 
part of this discussion. 
0) CONCLUSIONS. 
In the following I will discuss a possible sequence of demyelinating 
events, that was deduced from the studies presented here. This discussion 
starts at the end (the very process of myelin disruption) and 
subsequently works its way up the cascade of Interacting processes, wnich 
collaboratively regulate demyelinat i on, as Illustrated In Figure 2. 
Meanwhile, methods to study these processes will be discussed. 
The studies presented here addressed the possible terminal mechanisms of 
demyelinatlon, mainly on a molecular level, including proteolysis and 
complement activation, either specifically (triggered by antibodies) or 
nonspecifleally (by myelin or proteases). 
Although in some Instances demyelinatlon has been shown to occur in the 
absence of activated or infiltrating leucocytes, phagocytosis by 
macrophages Is generally considered to provide the main source of myelin 
removal. However, since there are Indications that phagocytosis is 
preceded by partial myelin disruption on a molecular level (Dal Canto et 
al. 1975), the primary and direct cause of disruption can be ascribed to 
molecular mechanisms like proteolysis or complement activation, with 
phagocytosis acting on a secondary, scavenger level. One of the possible 
mechanisms Inducing the phagocytosis of myelin, Is the opsonization of 
the layers In swollen myelin by specific antibodies and the subsequent 
invasion of the layers by macrophage processes. However, as in the case 
of Invasion of the myelin layers by macrophage processes during 
phagocytosis. It seems unlikely that antibodies alone are able to 
penetrate the tightly packed myelin layers without prior disruption 
caused by other processes, like swelling. 
As mentioned before, proteolysis disrupts the myelin Integrity, either 
directly, or Indirectly by activating complement. Released MBP possibly 
Increases or sustains proteolysis by Inactivating protease inhibitors. 
The fact that a myelin component (MBP) might enhance myelin breakdown, 
coupled to the nonspecific activation of complement by myelin, as well as 
its sensitivity for changes in salt concentrations or pH, could help to 
explain the relative vulnerability of myelin compared to other CNS-tissue 
components as an alternative mechanism for, or an addition to the 
Immune-specific myelin breakdown. 
The occurence of these processes has been examined, using the In vitro 
myelln-dlsruption assay, followed by the analysis of the bouyant density 
and the ultrastructure of myelin. The relation between an increase in 
myelin density and structural disruption seems present but needs further 
clarification, possibly using a chrcmlum-release assay. 
This basic system can be expanded by the incubation of myelin in the 
presence of cultured macrophages. Macrophages regulate myelin disruption 
in two ways: one Is by phagocytosis, as discussed earlier, the other by 
the excretion of disrupting factors. Among these factors is plasminogen 
activator, that converts serum plasminogen into ρ 1 asmi η, which in turn 
probably plays a role during demyellnation. The occurence of this process 
renders macrophages a source for molecular demye11 nat ing processes, 
besides their role in phagocytosis (see Figure 2). Studies concerning 
this concept are underway, and the preliminary results are promising, in 
that the shift in myelin density appears to be enhanced appreciably after 
the incubation of mye4in in the presence of thioglycolate elicited 
peritoneal macrophages (results not shown). 
Using the same system, the phagocytosis of myelin by macrophages can also 
be studied. One of the questions that can be addressed. Is whether 
macrophages phagocytose myelin with higher density more readily than 
normal myelin. Furthermore, It enables the study of disruption and 
phagocytosis, mediated by specific antibodies, most Interestingly PLP 
antibodies. 
The next step In the expansion of this system would be to study the effect 
of activated, myelIn-speclfie Τ lymphocytes, or their isolated cell 
products on the disruption of myelin, either through macrophage 
activation, or directly on myelin. This includes the study of Immune 
helper and suppressor mechanisms, a major focus In MS-related research. 
Alternatively, Τ lymphocytes specific for foreign antigens, like viruses, 
could be studied for their role In bystander demyellnation In vitro. 
These cellular additions yield a model, that potentially resembles myelin 
disruption in vivo closely, partly because many autologous components can 
be used. 
The elucidation of the sequence of events, resulting in demyellnation, 
particularly the Initial processes. Is essential for the understanding of 
its regulation by Immune mechanisms during the induction of autoimmunity 
in susceptible individuals, but also during its prevention, which 
apparently occurs In healthy individuals, despite various insults on the 
integrity of their vulnerable nervous system. 
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CHAPTER IX 
SAMENVATTING / SUMMARY 
IX. SAMENVATTING. 
SPECIFIEKE EN ASPECIFIEKE PROCESSEN IN DE 
AUTOIMMUNOLOGISCHE AFBRAAK VAN MYELINE. 
Multiple sclerosis (MS) is histologisch bezien gekenmerkt door verspreide 
demyelinisatie en infiltratie van centraal zenuwweefsel door leucocyten. De 
relatie tussen beide processen is onduidelijk en kan effectiever bestudeerd 
worden in de experimentele autoimmune encephalomyelitis (EAE), een veelvuldig 
gebruikt diermodel voor MS (hoewel een rol voor autoImmuniteit in MS (nog) 
niet bewezen is). Beide histologische processen zijn bestudeerd en de 
resultaten zijn in dit proefschrift weergegeven. 
De introductie geeft een inleidend overzicht van de recente literatuur 
betreffende de cellulaire infiltratie in het centraal zenuwstelsel (CZS). 
zowel met betrekking tot het mechanisme achter de infiltratie, als de 
identiteit van de betrokken cellen. Vervolgens wordt de literatuur aangaanae 
demyelinisatie besproken, hetgeen opgesplitst is in inductie- en 
effectormechanismen. Onder het laatste wordt uitvoerig aandacht aan 
immuun-aspeclfieke mechanismen besteed, aangezien deze processen zowel een 
effector-rol kunnen vervullen voor immuun-speclfieke processen, als 
onafhankelijk ervan demyelinisatie kunnen bewerkstelligen. Tenslotte bevat de 
introductie enige conclusies, die uit het hierin besprokene voortvloeien en 
aldus tot de specifieke doelstellingen van dit proefschrift Telden. 
In hoofdstuk II wordt de verspreiding van de subpopulaties van lymfocyten over 
verschillende compartimenten longitudinaal bestudeerd in een klassiex. acuut 
EAE model (nl. immunlsatie met ruggemerg). Hieruit kan geconcludeerd worden. 
dat infiltrerende suppressor-T-lymfocyten in de meninges accumuleren, terwijl 
helper-T-cellen dieper in het weefsel doordringen en derhalve mogelijk met 
demyelinisatie in verband gebracht kunnen worden. 
In hoofdstuk III is ter vergelijking de histopathologie van een recenter EAE 
model bestudeerd, nl. immun i sat Ie met het proteollpide protein (PLP) van 
centraal myéline. Hieruit bleek ondermeer, dat een gelijksoortige infiltratie 
plaatsvindt in vergel IJk ing met de EAE-induct Ie door middel van myéline 
basisch proteine (MBP) of compleet ruggemerg, terwijl immun i sat i e met PLP in 
vergelijking met MBP een chronischer ziekteverloop en meer demyelinisatie 
veroorzaakt. 
Hoofdstuk IV bevat een onderzoek naar een mogelijke oorzaak van de 
bovengenoemde verschillen tussen PLP- en MBP-geinduceerde EAE, namelijk de rol 
van PLP-anti1ichamen. Deze tonen een positieve correlatie met het 
ziekteverloop, waarbij de plek in de hoeveelheid circulerende anti lichamen 
voorafgaat aan de klinische verschijnselen, en zijn derhalve daarbij mogelijk 
betrokken. 
In de volgende drie hoofdstukken zijn immunologisch aspecifieke, humorale 
mechanismen met betrekking tot demyelinisatie bestudeerd. Zoals in de 
inleiding wordt bsproken, is op verschillende manieren aangetoond, dat 
proteolytische activiteit een belangrijke factor kan zijn in de feitelijke 
verstoring van de strakke organisatie in myéline in een vroeg stadium. 
Aangezien de protease-reramers hierbij een regulerende functie behoren te 
vervullen, die gezien de vaak voortdurende demyelinisatie mogelijk niet of 
onvoldoende tot stand komt, is de inactivatie van protease-remmers aoor 
geïsoleerd MBP in vitro bestudeerd (hoofdstuk V). 
Een mogelijk gevolg van de verhoogde proteolytische activiteit in de nabijheid 
van myéline is de act i vat i e van complement. Deze aspecifieke activât i e kan als 
versterking of zelfs als alternatief dienen voor de specifieke activatie van 
complement door immuuncomplexen. Derhalve is de rol van een complement-remmer 
(suramine) in de ontwikkeling van acute EAE bestudeerd, waarin is aangetoond. 
dat suramine zowel het klinische als het histologische verloop afremt, vooral 
na profylactische, doch eveneens na therapeutische toediening (hoofdstuk VI). 
In hoofdstuk VII is gepoogd een meer fysiologisch systeem te ontwikkelen, om 
het effect van enige voorgenoemde processen op myéline directer te kunnen 
bestuderen. Hierbij is, naast het gebruik van electronen-microscopie, ae 
dichtheid van myéline als parameter voor vroege myeline-afbraak 
geïntroduceerd. 
Tenslotte worden in hoofdstuk VIII de bevindingen van de voorgaande 
hoofdstukken in hun relatie tot elkaar besproken, hetgeen uitmondt in een 
hypothetische sequentie van de Inductie en de uitvoering van myeline-afbraak. 
SUMMARY 
MS is characterized histologically by multifocal demyel1nat ions and 
infiltration of the CNS by leucocytes. The relation between these processes is 
unclear and can be studied more effectively in EAE, an established animal 
model for MS (although evidence for any involvement of autoimmunity in MS has 
thusfar not been presented). The results of studies on both histological 
processes, using experimental models, are presented in this thesis. 
The introduction provides an overview of the recent literature concerning the 
cellular Infiltration of the CNS, in relation to both the mechanism behind the 
infiltration and the Identity of the cells Involved. Subsequently the 
literature concerning demyelinatlon is being discussed, divided Into Induction 
and effectuation mechanisms. In the latter, ample attention Is paid to 
immune-nonspecific processes, which can either act as effectors of 
immune-specific processes, or induce demyelinatlon independently. 
The last part of the introduction summarizes some conclusions, which lead to 
the specific aims of the current thesis. 
In chapter II the distribution of the lymphocyte subpopulations among different 
CNS compartments and the circulation is studied longitudinally in a classic, 
acute EAE model (i.e. Immunization with spinal cord). From this it can be 
concluded, that the infiltrating suppressor Τ lymphocytes accumulate in the 
meninges, while the helper Τ cells penetrate the tissue and could thus be 
Involved more directly in the demyelinatlon process. 
As comparison, the hlstopathology of a more recently developed EAE model is 
studied in chapter III, namely the immunization with PLP from central myelin. 
This showed that a similar type of infiltration occurs as in EAE induced with 
MBP or spinal cord, while immunization with PLP as compared to MBP results in 
a more chronic disease with more demyelinatlon. 
Chapter IV contains studies into a possible reason for the aforementioned 
differences between PLP and MBP Induced EAE, namely the involvement of PLP 
antibodies. Since these show a positive correlation with the disease course, 
while the peak quantity in circulating antibodies precedes the clinical signs, 
PLP antibodies could be Involved In the disease development. 
In the next three chapters, immunologically nonspecific, humoral mechanisms 
Involved in demyelinatlon are studied. As discussed in the introduction, 
several lines of evidence strongly suggest, that proteolytic activity forms an 
important factor in the actual disruption of the tight organization in myelin 
at an early stage. Since protease Inhibitors are thought to regulate this 
activity, which in view of the continuing demyelInatlon is possibly 
established insufficiently, the inactivation of protease inhibitors by 
purified MBP is studied in vitro (chapter V). 
A potential consequence of the increased proteolytic activity in the proximity 
of myelin is the activation of complement. This form of nonspecific activation 
can act as enhancer or even as alternative for the specific activation of 
complement through immune complexes. Since complement is also involved in 
vascular leakage, the effect of the complement inhibitor suramin on the 
development of acute EAE Is studied. This showed that suramin Inhibits both 
the clinical and histological course, more so after profylactlc, but also 
after therapeutic administration (chapter VI). 
In chapter VII attempts are made to develop a more physiological system, in 
order to study the effect of the processes discussed thusfar on myelin more 
directly. Besides the use of electron microscopy, the density of myelin has 
been Introduced as a parameter for myelin disruption. 
Finally, the results of the preceding chapters are discussed in their relation 
to each other, which leads to a hypothetical sequence of the Induction and 
execution of myelin breakdown. 
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STELLINGEN 
behorende bij het proefschrift van R.C. van der Veen 
Lymfосуten met het suppressor/cytotoxisch fenotype blijken, vanwege hun 
relatieve afwezigheid In parenchymaIe Infiltraten, niet betrokken te zijn bij 
de regulatie van demyelInlsatle tijdens de acute EAE-fase In ratten. 
De correlatie tussen de hoeveelheid circulerende PLP-antillchamen en de 
erop volgende ziekte-activltelt In konijnen suggereert, dat deze 
anti lichamen een functie In de ontwikkeling van EAE vervullen. 
Gezuiverd MBP versterkt de proteolytische activiteit en de myellne-afbraak 
door serumcomponenten In vitro. Het bewijzen van een overeenkomstige rol in 
vivo kan evenzeer belangrijk als moeilijk zijn. 
Hoewel het mechanisme nog onduidelijk is, blijkt de dichtheid van 
myéline toe te nemen tijdens de vroege fase van myeline-afbraak in vitro en 
Is daarom een potentiële parameter voor dit proces. 
Humorale processen, zoals protease- en complement-activiteit, zijn 
tenminste gedeeltelijk verantwoordelijk voor de tot stand koming van 
myeline-afbraak. De activât ie van deze processen kan waarschijnlijk 
geïnduceerd worden door zowel inmuun-specifleke als nonspeclfieke 
mechanismen. 
Omdat het onderzoek naar de activering van immuniteit in sommige 
landen ruimschoots gefinancleerd wordt, b.v. voor AIDS-research. zou dit ook 
mogelijk moeten zijn voor het onderzoek naar de suppressie van immuniteit. 
De centrale rol voor de binding van peptide-anti genen aan Ia-moleculen in 
antigen-presenterende cellen lijkt tegenstrijdig aan de gevoelige specifIteit 
van de antigen-receptoren op de T-cellen, die het antigen gepresenteerd 
krijgen. Een aantrekkelijke hypothese vormt echter de mogelijkheid dat de 
binding aan Ia het antigene peptide beschermt tegen verdere intracellulaire 
degradatie en tevens de enige voorwaarde is voor de immunogeniciteit van deze 
peptides. 
Hoewel veel antieke en als alternatief beschouwde voedingsleren een 
enigszins religieuze, onwetenschappelijke basis hebben, blijkt het toch 
mogelijk om sarai i ge mythen met de huidige, meer wetenschappelijke 
voedingskennis te rationaliseren. 
Een psychologische studie naar het effect van verschillende vormen van 
hoger onderwijs toont aan, dat psychologie-studenten, meer dan In andere 
studierichtingen, beter leren te redeneren in ongerelateerde 
probleemgebieden (R.E.Nibett et al., Science 238: 625-631, 19Θ7). 



